{"SLR NAME":"Systematic Review and Meta-Analysis of Sex-Specific COVID-19 Clinical Outcomes","References":[{"title1":"SARS-CoV-2 in Spanish Intensive Care Units: Early experience with 15-day survival in Vitoria","References":[{"title2":"health security for a coronavirus epidemic","References":[{"title3":"Emerging respiratory tract infections"},{"title3":"Emerging and reemerging infectious diseases: global overview"},{"title3":"Severe acute respiratory syndrome vs. the Middle East respiratory syndrome"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health: the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Toning down the 2019-nCoV hype - and restoring hope"},{"title3":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China"},{"title3":"Passengers' destinations from China: low risk of Novel Coronavirus (2019-nCoV) transmission into Africa and South America"},{"title3":"Statement in support of the scientists, public health professionals, and medical professionals of China combatting COVID-19"},{"title3":"Covid-19: a puzzle with many missing pieces"},{"title3":"2019-nCoV in context: lessons learned?"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"},{"title3":"Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China"},{"title3":"WHO Scientific and Technical Advisory Group for infectious hazards. COVID-19: what is next for public health?"},{"title3":"Reducing mortality from 2019-nCoV: host-directed therapies should be an option"}]},{"title2":"Coronavirus disease 2019 (COVID-19): a critical care perspective beyond China","References":[{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain"},{"title3":"[The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]"},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia"},{"title3":"Corticosteroid therapy in patients with primary viral pneumonia due to pandemic (H1N1) 2009 influenza"},{"title3":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome"},{"title3":"Strengthening ICU health security for a coronavirus epidemic"},{"title3":"Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR"},{"title3":"Situations Leading to Reduced Effectiveness of Current Hand Hygiene against Infectious Mucus from Influenza Virus-Infected Patients"},{"title3":"Critical care management of adults with community-acquired severe respiratory viral infection"},{"title3":"Noninvasive ventilation in critically ill patients with the Middle East respiratory syndrome"},{"title3":"The effects of azithromycin on patients with diffuse panbronchiolitis: a retrospective study of 29 cases"},{"title3":"Should noninvasive ventilation be considered a high-risk procedure during an epidemic?"},{"title3":"High-flow nasal therapy in adults with severe acute respiratory infection: a cohort study in patients with 2009 influenza A/H1N1 v"}]},{"title2":"Potential legal liability for withdrawing or withholding ventilators during COVID-19: assessing the risks and identifying needed reforms","References":[]},{"title2":"Covid-19 in critically Ill patients in the Seattle Region - Case Series","References":[{"title3":"Novel coronavirus : China"},{"title3":"Coronavirus COVID-19 global cases"},{"title3":"First case of 2019 novel coronavirus in the United States."},{"title3":"2019 Novel coronavirus outbreak (COVID-19)"},{"title3":"Cryptic transmission of novel coronavirus revealed by genomic epidemiology"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study."},{"title3":"Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response."},{"title3":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State."},{"title3":"Priorities for the US health community responding to COVID-19."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Coronavirus disease 2019 (COVID-19)"},{"title3":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR."},{"title3":"Clinical characteristics of coronavirus disease 2019 in China."},{"title3":"Early neuromuscular blockade in the acute respiratory distress syndrome."},{"title3":"Prone positioning in severe acute respiratory distress syndrome."},{"title3":"Bacterial coinfection in influenza: a grand rounds review."},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study."},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients."},{"title3":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome."},{"title3":"Corticosteroids as adjunctive therapy in the treatment of influenza: an updated Cochrane systematic review and meta-analysis."},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China."},{"title3":"Care of the critically ill and injured during pandemics and disasters: groundbreaking results from the Task Force on Mass Critical Care."},{"title3":"Introduction and executive summary: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement."}]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"Covid-19 Does Not Lead to a &quot;Typical&quot; Acute Respiratory Distress Syndrome","References":[]},{"title2":"Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: Interim guidance, V., 1.2","References":[]},{"title2":"Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain","References":[{"title3":"Pandemic (H1N1) 2009. Update 62"},{"title3":"Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico"},{"title3":"Hospitalized patients with novel influenza A (H1N1) virus infection - California, April-May, 2009"},{"title3":"Intensive-care patients with severe novel influenza A (H1N1) virus infection - Michigan, June 2009"},{"title3":"Situation Report. Pandemic Influenza (H1N1) 2009"},{"title3":"CDC protocol of realtime RTPCR for influenza A (H1N1). Geneva: World Health Organization, April 2009"},{"title3":"H1N1 2009 influenza virus infection during pregnancy in the USA"},{"title3":"Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults"},{"title3":"Viral pneumonia due to influenza and parainfluenza viruses and adenoviruses"},{"title3":"Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of Acute Dialysis Quality Initiative (ADQI) Group"},{"title3":"APACHE II: a severity of disease classification system"},{"title3":"The SOFA (Sepsis-Related Organ Failure Assessment) score to describe organ dysfunction/failure"},{"title3":"Vigilancia de la gripe en Espana"},{"title3":"Life-threatening respiratory failure from H1N1 influenza 09 (human swinw influenza)"},{"title3":"Influenza A virus infection and pulmonary microthormboembolism"},{"title3":"Seasonal influenza in adults and children- diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Disease society of America"},{"title3":"Update on avian influenza A (H5N1) virus infection in humans"},{"title3":"Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada"}]},{"title2":"Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis","References":[{"title3":"Emerging coronaviruses: Genome structure, replication, and pathogenesis"},{"title3":" National Health Commission of the People's Republic of China. 2020 Apr 5 [cited 2020 Apr 21]; Available from: . "},{"title3":" World Health Organization website. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003 (based on data as of December 31, 2003). 2015 Jul 24 [cited Sep 15]; Available from: . "},{"title3":" World Health Organization website. Middle East respiratory coronavirus syndrome (MERS-COV). 2019 Janu 19 [cited Sep 14]; Available from: . "},{"title3":"Coronavirus infections:more than just the common cold"},{"title3":"Journey of a Thai taxi driver and novel coronavirus"},{"title3":" Coronavirus disease (COVID-19) outbreak. 2020 Dec 11 [cited 2020 Sep 13]. Available from: . "},{"title3":" Coronavirus disease 2019 (COVID-19) Situation Report - 66. 2020 Mar 26 [cited 2020 Sep 17]. Available from: . "},{"title3":" Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). 2020 Feb 24 [cited 2020 Sep 16]. Available from: . "},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series"},{"title3":"Epidemiologic and clinical characteristics of 91 hospitalized patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series"},{"title3":"Epidemiological and clinical characteristics of COVID-19 in adolescents and young adults"},{"title3":" Reported cases and deaths by country, territory, or conveyance. 2020 Apr 10 [cited 2020 Apr 11]; Available from: . "},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement"},{"title3":"A structural equation model to examine the clinical features of mild-to-moderate COVID-19: A multicenter Italian study"},{"title3":"Clinical features and outcomes of COVID-19 patients with gastrointestinal symptoms"},{"title3":"Clinical features and short-term outcomes of 102 patients with corona virus disease 2019 in Wuhan, China"},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China"},{"title3":"Clinical features and chest CT manifestations of coronavirus disease 2019 (COVID-19) in a single-center study in Shanghai, China"},{"title3":"Clinical features, laboratory findings and predictors of death in hospitalized patients with COVID-19 in Sardinia, Italy"},{"title3":"Clinical features of cases and a cluster of Coronavirus Disease 2019 (COVID-19) in Bolivia imported from Italy and Spain"},{"title3":"Clinical features of COVID-19-related liver damage"},{"title3":"COVID-19 with different severities: a multicenter study of clinical features"},{"title3":"Demographic and clinical features of critically ill patients with COVID-19 in Greece: The burden of diabetes and obesity"},{"title3":"Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China"},{"title3":"Clinical characteristics of laboratory confirmed positive cases of SARS-CoV-2 infection in Wuhan, China: A retrospective single center analysis"},{"title3":"Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms"},{"title3":"Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province"},{"title3":"Novel coronavirus (2019-nCoV) cases in Hong Kong and implications for further spread"},{"title3":" Li J, Li S, Cai Y, Liu Q, Li X, Zeng Z, et al. Epidemiological and clinical characteristics of 17 hospitalized patients with 2019 Novel Coronavirus infections outside Wuhan, China. medRxiv [Internet] 2020; Available from; doi.org/10.1101/2020.02.11.20022053. "},{"title3":"Clinical characteristics of 25 death cases with COVID-19: a retrospective review of medical records in a single medical center, Wuhan, China"},{"title3":"Asymptomatic and symptomatic patients with non-severe coronavirus disease (COVID-19) have similar clinical features and virological courses: a retrospective single center study"},{"title3":"Clinical and transmission characteristics of Covid-19:a retrospective study of 25 cases from a single thoracic surgery department"},{"title3":"Analysis of epidemiological and clinical features in older patients with coronavirus disease 2019 (COVID-19) outside Wuhan"},{"title3":"Clinical and CT imaging features of the COVID-19 pneumonia: Focus on pregnant women and children"},{"title3":"Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients"},{"title3":"Analysis of clinical features and early warning signs in patients with severe COVID-19: A retrospective cohort study"},{"title3":"Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study"},{"title3":"Epidemiological and clinical features of 2019 novel coronavirus diseases (COVID-19) in the South of Iran"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Characteristics of COVID-19 infection in Beijing"},{"title3":"Clinical features and treatment of COVID-19 patients in northeast Chongqing"},{"title3":"The clinical dynamics of 18 cases of COVID-19 outside of Wuhan, China"},{"title3":"Epidemiological and clinical features of 125 Hospitalized Patients with COVID-19 in Fuyang, Anhui, China"},{"title3":"Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China"},{"title3":" Wu J, Liu J, Zhao X, Liu C, Wang W, Wang D, et al. Clinical characteristics of imported cases of COVID-19 in Jiangsu province: a multicenter descriptive study. Clin Infect Dis. [Internet] 2020; Available from: . "},{"title3":"Chest CT findings in patients with coronavirus disease 2019 and its relationship with clinical features"},{"title3":"Clinical features and dynamics of viral load in imported and non-imported patients with COVID-19"},{"title3":"Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2"},{"title3":"Clinical and computed tomographic imaging features of Novel Coronavirus Pneumonia caused by SARS-CoV-2"},{"title3":"Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): A multi-center study in Wenzhou city, Zhejiang, China"},{"title3":"Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China"},{"title3":"Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China"},{"title3":"Epidemiological, clinical characteristics of cases of SARS-CoV-2 infection with abnormal imaging findings"},{"title3":"A comparative study on the clinical features of COVID-19 pneumonia to other pneumonias"},{"title3":"The characteristics and clinical value of chest CT images of novel coronavirus pneumonia"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Initial clinical features of suspected coronavirus disease 2019 in two emergency departments outside of Hubei, China"},{"title3":"Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis"},{"title3":"Defining the epidemiology of Covid-19:studies needed"},{"title3":"The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?"},{"title3":"Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic"},{"title3":"The reproductive number of COVID-19 is higher compared to SARS coronavirus"},{"title3":"Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan: A Retrospective Observational Study"},{"title3":"The clinical and chest CT features associated with severe and critical COVID-19 pneumonia"}]},{"title2":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","References":[]},{"title2":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) in Mexico"},{"title3":"Critically ill patients with severe acute respiratory syndrome"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"KDIGO clinical practice guideline for acute kidney injury"},{"title3":"Wuhan: Britons to be evacuated as scientists estimate 44 000 cases of 2019-nCOV in the city"},{"title3":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome"},{"title3":"Short-term outcome of critically ill patients with severe acute respiratory syndrome"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries"},{"title3":"China built a hospital in 10 days to battle coronavirus"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Asymptomatic cases complicate efforts"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"},{"title3":"Practice of diagnosis and management of acute respiratory distress syndrome in mainland China: a cross-sectional study"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"}]},{"title2":"Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis","References":[{"title3":"World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report - 49. Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/. Last accessed, March 9, 2020."},{"title3":"Which lessons shall we learn from the 2019 novel coronavirus outbreak?"},{"title3":"Toward a holistic approach for diagnosing sepsis in the emergency department"},{"title3":"Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical Characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Measuring inconsistency in meta-analyses"},{"title3":"Laboratory abnormalities in patients with COVID-2019 infection"},{"title3":"Association of procalcitonin value and bacterial coinfections in pediatric patients with viral lower respiratory tract infections admitted to the pediatric intensive care unit"}]},{"title2":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State","References":[]},{"title2":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy","References":[{"title3":"The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European society of intensive care medicine"},{"title3":"New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey"}]},{"title2":"Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation","References":[]}]},{"title1":"Covid-19 in Critically Ill Patients in the Seattle Region — Case Series","References":[{"title2":"Novel coronavirus : China","References":[]},{"title2":"Coronavirus COVID-19 global cases","References":[{"title3":"ThWorld Health Organization Declares COVID-19 a 'Pandemic.' Here's What That Means"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Daily Report by Baidu"},{"title3":"Guidelines for Laboratory Diagnosis of Coronavirus Disease 2019 (COVID-19) in Korea"},{"title3":"False-negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: Rather than recurrence"},{"title3":"A Systematic Review of COVID-19 Epidemiology Based on Current Evidence"},{"title3":"Contributions to the mathematical theory of epidemics:I"},{"title3":"Effects of media reporting on mitigating spread of COVID-19 in the early phase of the outbreak"},{"title3":"European Centre for Disease Prevention and Control"},{"title3":"Wikipedia (English) &quot;COVID-19 Testing&quot;"},{"title3":"Greedy Function Approximation: A Gradient Boosting Machine"},{"title3":"Scikit-learn: Machine Learning in Python"},{"title3":"Scikit-Learn"},{"title3":"Python Software Foundation"},{"title3":"Average Detection Rate of SARS-CoV-2 Infections is Estimated around Six Percent"},{"title3":"On the origin and continuing evolution of SARS-CoV-2"},{"title3":"CCR5Delta32 mutation and HIV infection: Basis for curative HIV therapy"},{"title3":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor"},{"title3":"X chromosome gene expression in human tissues: Male and female comparisons"},{"title3":"The association between angiotensin-converting enzyme 2 polymorphisms and essential hypertension risk: A meta-analysis involving 14,122 patients"},{"title3":"The ACE2 G8790A Polymorphism: Involvement in Type 2 Diabetes Mellitus Combined with Cerebral Stroke"},{"title3":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance"},{"title3":"The CXCL1 rs4074 A allele is associated with enhanced CXCL1 responses to TLR2 ligands and predisposes to cirrhosis in HCV genotype 1-infected Caucasian patients"},{"title3":"Plasma levels of growth-related oncogene (CXCL1-3) associated with fibrosis and platelet counts in HCV-infected patients"},{"title3":"SNPedia: A wiki supporting personal genome annotation, interpretation and analysis"},{"title3":"The BCG World Atlas: A database of global BCG vaccination policies and practices"},{"title3":"BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity"},{"title3":"Tumor necrosis factor-alpha and interleukin-1 beta play a critical role in the resistance against lethal herpes simplex virus encephalitis"}]},{"title2":"First case of 2019 novel coronavirus in the United States.","References":[{"title3":"Pneumonia of unknown cause : China."},{"title3":"Novel coronavirus : China."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"2019 Novel coronavirus, Wuhan, China: 2019-nCoV situation summary."},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam."},{"title3":"Wuhan coronavirus (2019-nCoV) global cases"},{"title3":"Interim guidance for healthcare professionals: criteria to guide evaluation of patients under investigation (PUI) for 2019-nCoV."},{"title3":"Infection control. 2019 Novel coronavirus, Wuhan, China."},{"title3":"A randomized, controlled trial of ebola virus disease therapeutics."},{"title3":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV."},{"title3":"Interim guidelines for collecting, handling, and testing clinical specimens from patients under investigation (PUIs) for 2019 novel coronavirus (2019-nCoV)."},{"title3":"Real-time RT-PCR panel for detection 2019-novel coronavirus."},{"title3":"2019-novel coronavirus (2019-nCoV) real-time rRT-PCR panel primers and probes."},{"title3":"Information for laboratories. 2019 novel coronavirus, Wuhan, China."},{"title3":"GenBank overview"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Novel coronavirus outbreak 2020"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."}]},{"title2":"2019 Novel coronavirus outbreak (COVID-19)","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [published correction appears in Lancet. 2020 Jan 30]"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Correlation of chest CT and RT-PCR testing for coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases"},{"title3":"Detection of SARS-CoV-2 in different types of clinical specimens"},{"title3":"Variation in false-negative rate of reverse transcriptase polymerase chain reaction-based SARS-CoV-2 tests by time since exposure"},{"title3":"Xie X, Zhong Z, Zhao W, Zheng C, Wang F, Liu J (2020) Chest CT for typical 2019nCoV pneumonia: relationship to negative RT-PCR testing. Radiology. 10.1148/radiol.2020200343"},{"title3":"Use of chest CT in combination with negative RT-PCR assay for the 2019 novel coronavirus but high clinical suspicion"},{"title3":"Chest computed tomography and lung ultrasound findings in COVID-19 pneumonia: a pocket review for non-radiologists"},{"title3":"Lung ultrasound may support diagnosis and monitoring of COVID-19 pneumonia"},{"title3":"Relation between chest CT findings and clinical conditions of coronavirus disease (COVID-19) pneumonia: a multicenter study"},{"title3":"Performance of radiologists in differentiating COVID-19 from non-COVID-19 viral pneumonia at chest CT"},{"title3":"CT imaging features of 2019 novel coronavirus (2019-nCoV)"},{"title3":"Is there a role for lung ultrasound during the COVID-19 pandemic"},{"title3":"Thoracic ultrasonography: a narrative review"},{"title3":"Proposal for international standardization of the use of lung ultrasound for patients with COVID-19: a simple, quantitative, reproducible method"},{"title3":"Detection of SARS-coV-2 in different types of clinical specimens"},{"title3":"On Lung Ultrasound patterns specificity in the management of COVID-19 patients"},{"title3":"Point-of-care lung ultrasound in patients with COVID-19:a narrative review"},{"title3":"DGRT n. 669 del 18-06-2018. Allegato A &quot;Modello organizzativo dell'Emergenza Pediatrica Ospedaliera. Linee di indirizzo.&quot; (2018) http://www.quotidianosanita.it/allegati/allegato3489968.pdf"},{"title3":"DGRT n.1380/2016 &quot;Reti cliniche tempo-dipendenti di cui al D.M. 70/2015. Approvazione documenti di programmazione delle reti regionali.&quot; Allegato C. (2016) https://www.regione.toscana.it/bancadati/atti/Contenuto.xml?id=5135888&amp;nomeFile=Delibera_n.1380_del_27-12-2016-Allegato-C"},{"title3":"World Health Organization (2020) Global surveillance for COVID-19 caused by human infection with COVID-19 virus: interim guidance. 20 March 2020. WHO/2019-nCoV/SurveillanceGuidance/2020.6"},{"title3":"World Health Organization (2020) Laboratory testing of human suspected cases of novel coronavirus (nCOV) infection: interim guidance January 12, 2020. https://apps.who.int/iris/bitstream/handle/10665/330374/WHO-2019-nCoV-laboratory-2020.1-eng.pdf"},{"title3":"Ministero della Salute (2016) Ministero della Salute:Assistenza, ospedale e territorio:118 e Pronto Soccorso:I codici colore gravita (triage). Ref type: online source"},{"title3":"Updated Manchester triage system published this month"},{"title3":"Accademia di Ecografia Toracica:Pleural Hubbers Team (2019) COVID-19 MANAGEMENT poster. https://www.ordine-medici-firenze.it/modulistica-docman/varie/311-adet/file. Ref type: online source"},{"title3":"World Health Organization (2020) Clinical management of COVID-19. Interim guidance 27 May 2020. WHO/2019-nCoV/clinical/2020.5"},{"title3":"CT imaging features of novel coronavirus (2019-nCoV)"},{"title3":"Societa Italiana di Emergenza Urgenza (SIMEU) (2019) Rapporto Prima Linea COVID-19_ecografia. https://www.simeu.it/w/articoli/leggiArticolo/4031/leggi. Ref type: online source"},{"title3":"http://www301.regione.toscana.it/bancadati/atti/Contenuto.xml?id=5247300&amp;nomeFile=Ordinanza_del_Presidente_n.14_del_17-03-2020-Allegato-A (2020). Ref type: online source"},{"title3":"COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal"}]},{"title2":"Cryptic transmission of novel coronavirus revealed by genomic epidemiology","References":[]},{"title2":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) in Mexico"},{"title3":"Critically ill patients with severe acute respiratory syndrome"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"KDIGO clinical practice guideline for acute kidney injury"},{"title3":"Wuhan: Britons to be evacuated as scientists estimate 44 000 cases of 2019-nCOV in the city"},{"title3":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome"},{"title3":"Short-term outcome of critically ill patients with severe acute respiratory syndrome"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries"},{"title3":"China built a hospital in 10 days to battle coronavirus"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Asymptomatic cases complicate efforts"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"},{"title3":"Practice of diagnosis and management of acute respiratory distress syndrome in mainland China: a cross-sectional study"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"}]},{"title2":"Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response.","References":[]},{"title2":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State.","References":[]},{"title2":"Priorities for the US health community responding to COVID-19.","References":[]},{"title2":"Acute respiratory distress syndrome: the Berlin Definition.","References":[]},{"title2":"Coronavirus disease 2019 (COVID-19)","References":[]},{"title2":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR.","References":[{"title3":"World Health Organization (WHO). Coronavirus. Geneva: WHO; 2020 [Accessed 21 Jan 2020]. Available from: https://www.who.int/health-topics/coronavirus "},{"title3":"Zhang Y-Z. Novel 2019 coronavirus genome. Virological. [Accessed 21 Jan 2020]. Available from: http://virological.org/t/novel-2019-coronavirus-genome/319 "},{"title3":"de Groot RJ, Baker SC, Baric R, Enjuanes L, Gorbalenya AE, Holmes KV, et al. Family Coronaviridae. In: King AMQ, Adams MJ, Carstens EB, Lefkowitz EJ. Virus taxonomy: classification and nomenclature of viruses: ninth report of the International Committee on Taxonomy of Viruses. London; Waltham: Academic Press; 2012. p. 806-20."},{"title3":"The severe acute respiratory syndrome."},{"title3":"World Health Organization. (WHO. Novel Coronavirus (2019-nCoV). Situation report - 1. Geneva: WHO; 21 Jan 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov.pdf "},{"title3":"SARS testing: First past the post."},{"title3":"Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Specific detection by real-time reverse-transcription PCR assays of a novel avian influenza A(H7N9) strain associated with human spillover infections in China."},{"title3":"Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction."},{"title3":"Coordinated implementation of chikungunya virus reverse transcription-PCR."},{"title3":"Assay optimization for molecular detection of Zika virus."},{"title3":"Genomic characterization of severe acute respiratory syndrome-related coronavirus in European bats and classification of coronaviruses based on partial RNA-dependent RNA polymerase gene sequences."},{"title3":"Attenuation of replication by a 29 nucleotide deletion in SARS-coronavirus acquired during the early stages of human-to-human transmission."},{"title3":"Hosts and sources of endemic human coronaviruses."},{"title3":"Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS."},{"title3":"Origin and evolution of pathogenic coronaviruses."},{"title3":"The European Virus Archive goes global: A growing resource for research."},{"title3":"Developing a framework to assess the costeffectiveness of COMPARE - a global platform for the exchange of sequence-based pathogen data."},{"title3":"Need for additional capacity and improved capability for molecular detection of yellow fever virus in European Expert Laboratories: External Quality Assessment, March 2018."},{"title3":"First international external quality assessment of molecular diagnostics for Mers-CoV."},{"title3":"Advancing preparedness for clinical research during infectious disease epidemics."}]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China.","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Early neuromuscular blockade in the acute respiratory distress syndrome.","References":[{"title3":"Incidence and mortality of acute respiratory distress syndrome in children: a systematic review and meta-analysis"},{"title3":"The acute respiratory distress syndrome"},{"title3":"Ventilator-induced lung injury: from the bench to the bedside"},{"title3":"Ventilator-associated lung injury"},{"title3":"Tidal hyperinflation during low tidal volume ventilation in acute respiratory distress syndrome"},{"title3":"Neuromuscular blockers in early acute respiratory distress syndrome"},{"title3":"Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials"},{"title3":"Early hepatic dysfunction is associated with a worse outcome in patients presenting with acute respiratory distress syndrome: a post-hoc analysis of the ACURASYS and PROSEVA studies"},{"title3":"Effect of neuromuscular blocking agents on gas exchange in patients presenting with acute respiratory distress syndrome"},{"title3":"Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome"},{"title3":"Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome"},{"title3":"Short-term effects of neuromuscular blockade on global and regional lung mechanics, oxygenation and ventilation in pediatric acute hypoxemic respiratory failure"},{"title3":"Early use of adjunctive therapies for pediatric acute respiratory distress syndrome: a PARDIE study"},{"title3":"Acute lung injury in children: therapeutic practice and feasibility of international clinical trials"},{"title3":"Mechanical ventilation strategies in children with acute lung injury: a survey on stated practice pattern*"},{"title3":"Nonpulmonary treatments for pediatric acute respiratory distress syndrome: proceedings from the Pediatric Acute Lung Injury Consensus Conference"},{"title3":"Recommendations for mechanical ventilation of critically ill children from the Paediatric Mechanical Ventilation Consensus Conference (PEMVECC)"},{"title3":"Early Neuromuscular Blockade in Children with Pediatric Acute Respiratory Distress Syndrome"},{"title3":"Neuromuscular manifestations of critical illness"},{"title3":"Prospective documentation of sedative, analgesic, and neuromuscular blocking agent use in infants and children in the intensive care unit: a multicenter perspective"},{"title3":"Continuous-infusion neuromuscular blocking agents in critically ill neonates and children"},{"title3":"Allergic risk during paediatric anaesthesia"},{"title3":"ICU-Acquired Weakness Is Associated With Differences in Clinical Outcomes in Critically Ill Children"},{"title3":"Pediatric acute respiratory distress syndrome: consensus recommendations from the pediatric acute lung injury consensus conference"},{"title3":"The COMFORT behaviour scale detects clinically meaningful effects of analgesic and sedative treatment"},{"title3":"Nonrespiratory pediatric logistic organ dysfunction-2 score is a good predictor of mortality in children with acute respiratory failure"},{"title3":"Pediatric acute kidney injury in the ICU: an independent evaluation of pRIFLE criteria"},{"title3":"Reproducibility of childhood respiratory symptom questions"},{"title3":"Performance of commonly used respiratory questionnaire items in a cohort of infants born preterm"},{"title3":"Diagnosis and management of critical illness polyneuropathy and critical illness myopathy"},{"title3":"An Evaluation of Various Ventilator-Associated Infection Criteria in a PICU"},{"title3":"Consensus statement for inert gas washout measurement using multiple- and single- breath tests"},{"title3":"Reappraisal of Ventilator-Free Days in Critical Care Research"},{"title3":"Relationship between the functional status scale and the pediatric overall performance category and pediatric cerebral performance category scales"},{"title3":"Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support"},{"title3":"The REDCap consortium: Building an international community of software platform partners"},{"title3":"How safe is non-bronchoscopic bronchoalveolar lavage in critically ill mechanically ventilated children?"},{"title3":"Nonpulmonary Treatments for Pediatric Acute Respiratory Distress Syndrome: Proceedings From the Pediatric Acute Lung Injury Consensus Conference"},{"title3":"Functional Status Scale: new pediatric outcome measure"},{"title3":"Relevant Outcomes in Pediatric Acute Respiratory Distress Syndrome Studies"},{"title3":"Pediatric origins of adult lung disease. 1. The contribution of airway development to paediatric and adult lung disease"},{"title3":"Childhood respiratory illness and lung function at ages 14 and 50 years: childhood respiratory illness and lung function"},{"title3":"Early life origins of chronic obstructive pulmonary disease"},{"title3":"Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study"},{"title3":"Reduced PICU respiratory admissions during COVID-19"},{"title3":"Unplanned and medical admissions to pediatric intensive care units significantly decreased during COVID-19 outbreak in Northern Italy"}]},{"title2":"Prone positioning in severe acute respiratory distress syndrome.","References":[]},{"title2":"Bacterial coinfection in influenza: a grand rounds review.","References":[]},{"title2":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study.","References":[{"title3":"multi-country outbreak:update 34"},{"title3":"SARS coronavirus sequencing"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Atypical pneumonia"},{"title3":"Guideline on management of severe acute respiratory syndrome (SARS)"},{"title3":"HA guidelines on severe acute respiratory syndrome"},{"title3":"The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination"},{"title3":"APACHE II: a severity of disease classification system"},{"title3":"Rapid diagnosis of a coronavirus associated with severe acute respiratory syndrome (SARS)"},{"title3":"Differential role for T cells in the development of fibrotic lesions associated with reovirus 1/L-induced bronchiolitis obliterans organizing pneumonia versus acute respiratory distress syndrome"},{"title3":"Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fg12 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response"},{"title3":"Prevention of experimental coronavirus colds with intranasal alpha-2b interferon"},{"title3":"Radiological appearances of cytomegalovirus infections"},{"title3":"A case of influenza bronchiolitis complicated by pneumomediastinum and subcutaneous emphysema"}]},{"title2":"Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients.","References":[]},{"title2":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome.","References":[]},{"title2":"Corticosteroids as adjunctive therapy in the treatment of influenza: an updated Cochrane systematic review and meta-analysis.","References":[]},{"title2":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China.","References":[]},{"title2":"Care of the critically ill and injured during pandemics and disasters: groundbreaking results from the Task Force on Mass Critical Care.","References":[]},{"title2":"Introduction and executive summary: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement.","References":[{"title3":"Definitive care for the critically ill during a disaster: current capabilities and limitations: from a Task Force for Mass Critical Care summit meeting, January 26-27, 2007, Chicago, IL"},{"title3":"Refining surge capacity: conventional, contingency, and crisis capacity"},{"title3":"European Society of Intensive Care Medicine's Task Force for intensive care unit triage during an influenza epidemic or mass disaster. Chapter 2. Surge capacity and infrastructure considerations for mass critical care. Recommendations and standard operating procedures for intensive care unit and hospital preparations for an influenza epidemic or mass disaster"},{"title3":"Health care facility and community strategies for patient care surge capacity"},{"title3":"Task Force for Mass Critical Care. Summary of suggestions from the Task Force for Mass Critical Care summit, January 26-27, 2007"},{"title3":"Altevogt BM, Institute of Medicine. (U.S.). Committee on Guidance for Establishing Standards of Care for Use in Disaster Situations. Guidance for Establishing Crisis Standards of Care for Use in Disaster Situations: A Letter Report. Washington, DC: National Academies Press; 2009."},{"title3":"Task Force for Mass Critical Care. Definitive care for the critically ill during a disaster: a framework for allocation of scarce resources in mass critical care: from a Task Force for Mass Critical Care summit meeting, January 26-27, 2007, Chicago, IL"},{"title3":"Task Force for Mass Critical Care. Definitive care for the critically ill during a disaster: medical resources for surge capacity: from a Task Force for Mass Critical Care summit meeting, January 26-27, 2007, Chicago, IL"},{"title3":"Task Force for Mass Critical Care. Definitive care for the critically ill during a disaster: a framework for optimizing critical care surge capacity: from a Task Force for Mass Critical Care summit meeting, January 26-27, 2007, Chicago, IL"},{"title3":"Survey about responsiveness of third-level hospitals to a medical disaster: after the pandemic influenza in Mexico [in Spanish]"},{"title3":"H1N1 influenza: critical care aspects"},{"title3":"Hospital Civil de Guadalajara, Fray Antonio Alcalde Emerging Respiratory Infections Response Team. Hospital triage system for adult patients using an influenza-like illness scoring system during the 2009 pandemic:Mexico"},{"title3":"Preparing your intensive care unit for the second wave of H1N1 and future surges"},{"title3":"Planning for a pandemic: a view from the accident and emergency department"},{"title3":"Preparing for the sickest patients with 2009 influenza A(H1N1)"},{"title3":"Influenza A(H1N1) epidemic in Argentina. Experience in a National General Hospital (Hospital Nacional Profesor Alejandro Posadas) [in Spanish]"},{"title3":"Death toll climbs and healthcare needs escalate in Japan"},{"title3":"Boston's first-in-class first response"},{"title3":"The Boston Marathon response: why did it work so well?"},{"title3":"Emergency preparedness and public health: the lessons of Hurricane Sandy"},{"title3":"Hurricane Sandy and the greater New York health care system"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"KSA MERS-CoV Investigation Team. Hospital outbreak of Middle East respiratory syndrome coronavirus"},{"title3":"Chemical weapons. U.N. taps special labs to investigate Syrian attack"},{"title3":"Lack of atropine in Syria hampers treatment after gas attacks [published correction appears in BMJ. 2013;347:f 5530]"},{"title3":"As Syria crisis mounts, scientist looks back at last major chemical attack"},{"title3":"on behalf of the Task Force for Mass Critical Care. Methodology: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement"},{"title3":"Barbera JA, Macintyre AG. Medical and Health Incident Management (MaHIM) System: A Comprehensive Functional System Description for Mass Casualty Medical and Health Incident Management. Washington, DC: Institute for Crisis, Disaster, and Risk Management, George Washington University; 2002"},{"title3":"Barbera JA, Macintyre AG. Medical Surge Capacity and Capability: A Management System for Integrating Medical and Health Resources During Large-Scale Emergencies. Washington, DC: US Department of Health and Human Services; 2004"},{"title3":"Clinical research ethics for critically ill patients: a pandemic proposal"},{"title3":"InFACT: a global critical care research response to H1N1"},{"title3":"PREEDICCT Study Group. Critical care resource allocation: trying to PREEDICCT outcomes without a crystal ball"}]}]},{"title1":"Clinical progression of patients with COVID-19 in Shanghai, China","References":[{"title2":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","References":[{"title3":"CHP closely monitors cluster of pneumonia cases on Mainland"},{"title3":"CHP provides further information on cluster of pneumonia cases in Wuhan"},{"title3":"Wuhan wet market closes amid pneumonia outbreak"},{"title3":"Viral load in patients infected with pandemic H1N1 2009 influenza A virus"},{"title3":"Saliva as a diagnostic specimen for testing respiratory virus by a point-of-care molecular assay: a diagnostic validity study"},{"title3":"Evaluation of NxTAG Respiratory pathogen panel and comparison with xTAG respiratory viral panel fast v2 and film array respiratory panel for detecting respiratory pathogens in nasopharyngeal aspirates and swine/avian-origin influenza A subtypes in culture isolates"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Zika virus infection in dexamethasone-immunosuppressed mice demonstrating disseminated infection with multi-organ involvement including orchitis effectively treated by recombinant type I interferons"},{"title3":"High prevalence of four novel astrovirus genotype species identified from rodents in China"},{"title3":"Metagenomic analysis of viromes of dromedary camel fecal samples reveals large number and high diversity of circoviruses and picobirnaviruses"},{"title3":"Identification of a novel bat papillomavirus by metagenomics"},{"title3":"Metagenomic nanopore sequencing of influenza virus direct from clinical respiratory samples"},{"title3":"Severe acute respiratory syndrome (SARS) coronavirus ORF8 protein is acquired from SARS-related coronavirus from greater horseshoe bats through recombination"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection"},{"title3":"A patient with asymptomatic severe acute respiratory syndrome (SARS) and antigenemia from the 2003-2004 community outbreak of SARS in Guangzhou, China"},{"title3":"Viral replication in the nasopharynx is associated with diarrhea in patients with severe acute respiratory syndrome"},{"title3":"Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease"},{"title3":"Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus"},{"title3":"Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"Viral loads in clinical specimens and SARS manifestations"},{"title3":"Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome"},{"title3":"Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia"},{"title3":"Discovery of seven novel mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus"},{"title3":"Discovery of a novel coronavirus, China Rattus coronavirus HKU24, from Norway rats supports the murine origin of Betacoronavirus 1 and has implications for the ancestor of Betacoronavirus lineage A"},{"title3":"Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Antigenic cross-reactivity between severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43"}]},{"title2":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","References":[{"title3":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses"},{"title3":"Coronavirus avian infectious bronchitis virus"},{"title3":"Pathogenicity of turkey coronavirus in turkeys and chickens"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Severe acute respiratory syndrome"},{"title3":"SARS: epidemiology"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"A dynamic compartmental model for the Middle East respiratory syndrome outbreak in the Republic of Korea: a retrospective analysis on control interventions and superspreading events"},{"title3":"The clinical and virological features of the first imported case causing MERS-CoV outbreak in South Korea, 2015"},{"title3":"A novel coronavirus genome identified in a cluster of pneumonia cases:Wuhan, China 2019-2020"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Two-tube multiplex real-time reverse transcription PCR to detect six human coronaviruses"},{"title3":"Fast and accurate short read alignment with Burrows-Wheeler transform"},{"title3":"RAPSearch2: a fast and memory-efficient protein similarity search tool for next-generation sequencing data"},{"title3":"Human infection with a novel, highly pathogenic avian influenza A (H5N6) virus: virological and clinical findings"},{"title3":"CDD/SPARCLE: functional classification of proteins via subfamily domain architectures"},{"title3":"Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination"},{"title3":"Parallelization of MAFFT for large-scale multiple sequence alignments"},{"title3":"RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies"},{"title3":"Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats"},{"title3":"Structure, function, and evolution of coronavirus spike proteins"},{"title3":"Bat-to-human: spike features determining 'host jump' of coronaviruses SARS-CoV, MERS-CoV, and beyond"},{"title3":"MERS-CoV spike protein: targets for vaccines and therapeutics"},{"title3":"Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine"},{"title3":"Evidence for a common evolutionary origin of coronavirus spike protein receptor-binding subunits"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26"},{"title3":"Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4"},{"title3":"Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26"},{"title3":"SWISS-MODEL: homology modelling of protein structures and complexes"},{"title3":"Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia"},{"title3":"Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin"}]},{"title2":"A new coronavirus associated with human respiratory disease in China","References":[]},{"title2":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected","References":[]},{"title2":"First case of 2019 novel coronavirus in the United States","References":[{"title3":"Pneumonia of unknown cause : China."},{"title3":"Novel coronavirus : China."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"2019 Novel coronavirus, Wuhan, China: 2019-nCoV situation summary."},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam."},{"title3":"Wuhan coronavirus (2019-nCoV) global cases"},{"title3":"Interim guidance for healthcare professionals: criteria to guide evaluation of patients under investigation (PUI) for 2019-nCoV."},{"title3":"Infection control. 2019 Novel coronavirus, Wuhan, China."},{"title3":"A randomized, controlled trial of ebola virus disease therapeutics."},{"title3":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV."},{"title3":"Interim guidelines for collecting, handling, and testing clinical specimens from patients under investigation (PUIs) for 2019 novel coronavirus (2019-nCoV)."},{"title3":"Real-time RT-PCR panel for detection 2019-novel coronavirus."},{"title3":"2019-novel coronavirus (2019-nCoV) real-time rRT-PCR panel primers and probes."},{"title3":"Information for laboratories. 2019 novel coronavirus, Wuhan, China."},{"title3":"GenBank overview"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Novel coronavirus outbreak 2020"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."}]},{"title2":"The first case of 2019 novel coronavirus pneumonia imported into Korea from Wuhan, China: Implication for infection prevention and control measures","References":[{"title3":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology"},{"title3":"Hosts and sources of endemic human coronaviruses"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A novel coronavirus from patients with Pneumonia in China, 2019"},{"title3":"Screening for influenza A(H1N1)pdm09, Auckland International Airport, New Zealand"},{"title3":"Clinical and epidemiologic characteristics of spreaders of middle east respiratory syndrome coronavirus during the 2015 outbreak in Korea"},{"title3":"Clinical progression and cytokine profiles of middle east respiratory syndrome coronavirus infection"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"}]},{"title2":"Importation and human-to-human transmission of a novel coronavirus in Vietnam","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."}]},{"title2":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"China coronavirus: six questions scientists are asking."}]},{"title2":"Note from the editors: world health organization declares novel coronavirus (2019-nCoV) sixth public health emergency of international concern","References":[]},{"title2":"World Health Organization. Coronavirus dieases 2019 (COVID-19) situation report - 40 2020[cited 2020 Mar 1st]. Available from:https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200229-sitrep-40-covid-19.pdf?sfvrsn=7203e653_2.","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China","References":[]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"A novel coronavirus from patients with pneumonia in China","References":[{"title3":"An update on the epidemiological characteristics of novel coronavirus pneumonia (COVID-19)"},{"title3":"World Health Organization [Internet]. Rolling updates on coronavirus disease (COVID-19). 2020 [cited 2020 11 March]. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen."},{"title3":"Coronavirus Disease 2019 (COVID-19): A Perspective from China"},{"title3":"An analysis of global research on SARS-CoV-2"},{"title3":"A Novel Coronavirus from Patients with Pneumonia in China, 2019"},{"title3":"Clinical Characteristics of Coronavirus Disease 2019 in China"},{"title3":"Clinical Characteristics of Imported Cases of Coronavirus Disease 2019 (COVID-19) in Jiangsu Province: A Multicenter Descriptive Study"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China"},{"title3":"COVID-19 length of hospital stay: a systematic review and data synthesis"},{"title3":"Risk factors associated with disease severity and length of hospital stay in COVID-19 patients"},{"title3":"COVID-19 Case Report: An 84-Year-Old Man with Exacerbation of Multiple Comorbidities Due to COVID-19 Managed by a Multidisciplinary Team Using Patient-Reported Outcomes"},{"title3":"Obesity prolongs the hospital stay in patients affected by COVID-19, and may impact on SARS-COV-2 shedding"},{"title3":"World Health Organization [Internet]. Novel Coronavirus (COVID-19) Situation. 2020 [cited 2020 9 March]. https://experience.arcgis.com/experience/685d0ace521648f8a5beeeee1b9125cd."},{"title3":"Study on progress of Infectious disease Prevention and Control in China"},{"title3":"Health Commission of Sichuan Province [Internet]. Health Resources. 2020 [cited 2020 Mar 1]. http://wsjkw.sc.gov.cn/scwsjkw/wszy/tygl.shtml."},{"title3":"General Office of National Health Commission, General Office of National Administration of Traditional Chinese Medicine [Internet]. Diagnostic and treatment protocol for Novel Coronavirus Pneumonia (Trial version 7). 2020 [cited 2020 Mar 3]. http://www.nhc.gov.cn/xcs/zhengcwj/202003/46c9294a7dfe4cef80dc7f5912eb1989.shtml."},{"title3":"Survival analysis and regression models"},{"title3":"Wikipedia [Internet]. Sichuan. 2020 [cited 2020 Mar 9]. https://en.wikipedia.org/wiki/Sichuan."},{"title3":"The People's Government of Sichuan Province [Internet]. The 41st executive meeting of sichuan provincial people's government. 2020 [cited 2020 Jan 21]. http://www.sc.gov.cn/10462/10464/10856/10857/2020/1/21/b8d453617c434fa4b9197f477fe94d7f.shtml."},{"title3":"The People's Government of Sichuan Province [Internet]. Ten questions about &quot;first level emergency response&quot;. 2020 [cited 2020 Jan 26]. http://www.sc.gov.cn/10462/c102250/2020/1/26/a869dd8500f54d8e8259fc0c95fdab54.shtml."},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China"},{"title3":"Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention"},{"title3":"Coronavirus covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate"},{"title3":"The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?"},{"title3":"COVID-19: Lessons from SARS and MERS"},{"title3":"COVID-19: Forecasting short term hospital needs in France"},{"title3":"Impact of sex and age on respiratory support and length of hospital stay among 1792 patients with COVID-19 in Wuhan, China"},{"title3":"Factors associated with the duration of hospitalisation among COVID-19 patients in Vietnam: A survival analysis"},{"title3":"What is the role of Primary Health Care in the COVID-19 pandemic?"},{"title3":"Retooling Primary Care in the COVID-19 Era"},{"title3":"The role and response of primary healthcare services in the delivery of palliative care in epidemics and pandemics: A rapid review to inform practice and service delivery during the COVID-19 pandemic"},{"title3":"Redesigning Primary Care to Address the COVID-19 Pandemic in the Midst of the Pandemic"},{"title3":"The Central People's Government of the People's Republic of China [Internet]. Notice on completing the basic public health service project in 2019. 2019 [cited 2019 Sep 5]. http://www.gov.cn/xinwen/2019-09/05/content_5427467.htm."},{"title3":"ChinaDaily [Internet]. COVID-19 more severe than influenza, says WHO chief. 2020 [cited 2020 Mar 4]. http://www.chinadaily.com.cn/a/202003/04/WS5e5ea17aa31012821727c087.html."},{"title3":"Milenkovic M, Russo CA, Elixhauser A (2006) Hospital Stays for Influenza, 2004: Statistical Brief #16. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville (MD): Agency for Healthcare Research and Quality (US)."},{"title3":"National Health Commission of the People's Republic of China [Internet]. Guidance for Corona Virus Disease 2019: Prevention, Control, Diagnosis and Management. 2020 [cited 2020 Mar 3]. https://mp.weixin.qq.com/s?__biz=MzAwNDE4Njk5MQ==&amp;mid=2736129023&amp;idx=1&amp;sn=d2719645230da1d6582d50d06726b9bb&amp;chksm=bdc%E2%80%A6."},{"title3":"World Health Organization [Internet]. Home care for patients with suspected novel coronavirus (COVID-19) infection presenting with mild symptoms, and management of their contacts. 2020 [cited 2020 4 February]. https://www.who.int/publications-detail/home-care-for-patients-with-suspected-novel-coronavirus-(ncov)-infection-presenting-with-mild-symptoms-and-management-of-contacts."},{"title3":"World Health Organization [Internet]. Coronavirus disease (COVID-19) technical guidance: Patient management. 2020 [cited 2020 4 February]. https://www.who.int/publications-detail/home-care-for-patients-with-suspected-novel-coronavirus-(ncov)-infection-presenting-with-mild-symptoms-and-management-of-contacts."},{"title3":"MEDBOX [Internet]. COVID-19 TOOLBOX. 2020 [cited 2020 Dec 30]. https://www.medbox.org/toolbox/5E6EA419CA7A4."},{"title3":"PAHO [Internet]. Hospital Readiness Checklist for COVID-19. 2020 [cited 2020 Feb 10]. https://iris.paho.org/handle/10665.2/52402?show=full."},{"title3":"World Health Organization [Internet]. Rapid Hospital Readiness Checklist 2020 [cited 2020 25 June]. https://apps.who.int/iris/rest/bitstreams/1284123/retrieve."},{"title3":"Defining the Epidemiology of Covid-19:Studies Needed"},{"title3":"Sichuan Provincial Bureau of Statistics [Internet]. Statistical yearbook of Sichuan Province. 2018 [cited 2019 Dec 30]. http://web.sctjj.cn/tjcbw/tjnj/2018/zk/indexch.htm."}]},{"title2":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in china: summary of a report of 72 314 cases from the chinese center for disease control and prevention","References":[]},{"title2":"Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, people's republic of China","References":[{"title3":"Epidemiological study on severe acute respiratory syndrome in Guangdong province"},{"title3":"Guangdong Public Health Office. 2003: Document No 2. Summary report of investigating an atypical pneumonia outbreak in Zhongshan (January 21, 2003)."},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Update: outbreak of severe acute respiratory syndrome-Worldwide, 2003"},{"title3":"Severe acute respiratory syndrome (SARS)"},{"title3":"Cumulative number of reported probable cases of severe acute respiratory syndrome (SARS)"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Case definitions for surveillance of severe acute respiratory syndrome (SARS)"},{"title3":"The Genome sequence of the SARS-associated coronavirus"},{"title3":"Emergence of multiple genotypes of H5N1 avian influenza viruses in Hong Kong SAR"},{"title3":"MEGA2: molecular evolutionary genetics analysis software"},{"title3":"Quantitation of relative fitness and great adaptability of clonal populations of RNA viruses"},{"title3":"RNA virus mutations and fitness for survival"},{"title3":"A pandemic warning?"},{"title3":"Characterisation of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness"},{"title3":"An influenza epicentre?"}]},{"title2":"Clinical presentation and outcomes of middle east respiratory syndrome in the republic of Korea","References":[{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Spread, circulation, and evolution of the Middle East respiratory syndrome coronavirus"},{"title3":"Family cluster of Middle East respiratory syndrome coronavirus infections"},{"title3":"2014 MERS-CoV outbreak in Jeddah--a link to health care facilities"},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus"},{"title3":"Middle East Respiratory Syndrome coronavirus outbreak in the Republic of Korea, 2015"},{"title3":"Multifacility Outbreak of Middle East Respiratory Syndrome in Taif, Saudi Arabia"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Antiviral treatment guidelines for Middle East respiratory syndrome"},{"title3":"Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study"}]},{"title2":"Coronavirus HKU1 and other coronavirus infections in Hong Kong","References":[]},{"title2":"Clinical progression and viral load in a community outbreak of coronavirus-associated sars pneumonia: a prospective study","References":[{"title3":"multi-country outbreak:update 34"},{"title3":"SARS coronavirus sequencing"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Atypical pneumonia"},{"title3":"Guideline on management of severe acute respiratory syndrome (SARS)"},{"title3":"HA guidelines on severe acute respiratory syndrome"},{"title3":"The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination"},{"title3":"APACHE II: a severity of disease classification system"},{"title3":"Rapid diagnosis of a coronavirus associated with severe acute respiratory syndrome (SARS)"},{"title3":"Differential role for T cells in the development of fibrotic lesions associated with reovirus 1/L-induced bronchiolitis obliterans organizing pneumonia versus acute respiratory distress syndrome"},{"title3":"Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fg12 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response"},{"title3":"Prevention of experimental coronavirus colds with intranasal alpha-2b interferon"},{"title3":"Radiological appearances of cytomegalovirus infections"},{"title3":"A case of influenza bronchiolitis complicated by pneumomediastinum and subcutaneous emphysema"}]},{"title2":"Coronavirus infections and immune responses","References":[]},{"title2":"Reducing mortality from 2019-nCoV: host-directed therapies should be an option","References":[{"title3":"Novel coronavirus (2019-nCoV) situation report - 14"},{"title3":"Severe acute respiratory syndrome: historical, epidemiologic, and clinical features"},{"title3":"The Middle East respiratory syndrome (MERS)"},{"title3":"Clinical features of patients infected with 2019 coronavirus in Wuhan, China"},{"title3":"Coronavirus infections and immune responses"},{"title3":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology"},{"title3":"Quality of life reported by survivors after hospitalization for Middle East respiratory syndrome (MERS)"},{"title3":"The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status"},{"title3":"Coronaviruses - drug discovery and therapeutic options"},{"title3":"Advances in respiratory virus therapeutics:a meeting report from the 6th ISIRV antiviral group conference"},{"title3":"Host-directed therapies for improving poor treatment outcomes associated with the Middle East respiratory syndrome coronavirus infections"},{"title3":"Effect of oral gavage treatment with ZnAL42 and other metallo-ion formulations on influenza A H5N1 and H1N1 virus infections in mice"},{"title3":"Cell therapy in acute respiratory distress syndrome"},{"title3":"Immune therapy in sepsis: are we ready to try again?"},{"title3":"Clinically relevant immune responses against cytomegalovirus: implications for precision medicine"}]},{"title2":"Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients","References":[]},{"title2":"Corticosteroid therapy for critically ill patients with middle east respiratory syndrome","References":[]},{"title2":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury","References":[]}]},{"title1":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title2":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle","References":[{"title3":"XINHUANET News Report"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Coronaviruses-drug discovery and therapeutic options"},{"title3":"Sequence-based identification of microbial pathogens: a reconsideration of Koch's postulates"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Molecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus-like virus in palm civets at an animal market and on farms"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"}]},{"title2":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China","References":[{"title3":"The Middle East Respiratory Syndrome (MERS)"},{"title3":"Severe acute respiratory syndrome: historical, epidemiologic, and clinical features"},{"title3":"Pneumonia in China: lack of information raises concerns among Hong Kong health workers"},{"title3":"Taking forward a' One Health' approach for turning the tide against the Middle East respiratory syndrome coronavirus and other zoonotic pathogens with epidemic potential"},{"title3":"ProMED &quot;Novel coronavirus - China (01): (HU) WHO, phylogenetic tree&quot;. Archive Number: 20200112.6885385. Accessed 13 Jan 2020. https://www.ecohealthalliance.org/2020/01/phylogenetic-analysis-shows-novel-wuhan-coronavirus-clusters-with-sars."}]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance","References":[]},{"title2":"MERS, SARS and other coronaviruses as causes of pneumonia","References":[{"title3":"Coronavirus pathogenesis"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"  . Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fact Sheet [Accessed 28 Aug 2017.] Available from URL: http://www.who.int/mediacentre/factsheets/mers-cov/en/."},{"title3":"Discovery of seven novel Mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus"},{"title3":"Evidence supporting a zoonotic origin of human coronavirus strain NL63"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Close relative of human Middle East respiratory syndrome coronavirus in bat, South Africa"},{"title3":"Molecular diversity of coronaviruses in bats"},{"title3":"Discovery of a novel coronavirus, China Rattus coronavirus HKU24, from Norway rats supports the murine origin of Betacoronavirus 1 and has implications for the ancestor of Betacoronavirus lineage A"},{"title3":"Transmission of Middle East respiratory syndrome coronavirus infections in healthcare settings, Abu Dhabi"},{"title3":"Middle East Respiratory syndrome coronavirus outbreak in the Republic of Korea, 2015"},{"title3":"Epidemiology, transmission dynamics and control of SARS: the 2002-2003 epidemic"},{"title3":"Clinical and epidemiologic characteristics of spreaders of Middle East respiratory syndrome coronavirus during the 2015 Outbreak in Korea"},{"title3":"Infectivity of an asymptomatic patient with Middle East respiratory syndrome coronavirus infection"},{"title3":"Clinical features and molecular epidemiology of coronavirus-HKU1-associated community-acquired pneumonia"},{"title3":"Severe acute respiratory syndrome (SARS): a year in review"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"Risk Factors for Primary Middle East Respiratory Syndrome Coronavirus Illness in Humans, Saudi Arabia, 2014"},{"title3":"Outbreaks of Middle East respiratory syndrome in two hospitals initiated by a single patient in Daejeon, South Korea"},{"title3":"First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013"},{"title3":"Coronavirus HKU1 and other coronavirus infections in Hong Kong"},{"title3":"Epidemiology of coronavirus-associated respiratory tract infections and the role of rapid diagnostic tests: a prospective study"},{"title3":"Prevalence and molecular epidemiology of human coronavirus HKU1 in patients with acute respiratory illness"},{"title3":"Viral infection in adults hospitalized with community-acquired pneumonia: prevalence, pathogens, and presentation"},{"title3":"Community-acquired pneumonia requiring hospitalization among U.S. adults"},{"title3":"Viral and Mycoplasma pneumoniae community-acquired pneumonia and novel clinical outcome evaluation in ambulatory adult patients in China"},{"title3":"Coronavirus spike proteins in viral entry and pathogenesis"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) in disease pathogenesis"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Dipeptidyl peptidase 4 distribution in the human respiratory tract: implications for the Middle East respiratory syndrome"},{"title3":"Differential expression of the Middle East respiratory syndrome coronavirus receptor in the upper respiratory tracts of humans and dromedary camels"},{"title3":"The multifunctional or moonlighting protein CD26/DPPIV"},{"title3":"Human aminopeptidase N is a receptor for human coronavirus 229E"},{"title3":"Pathogenic influenza viruses and coronaviruses utilize similar and contrasting approaches to control interferon-stimulated gene responses"},{"title3":"Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment"},{"title3":"Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC/2012: implications for disease pathogenesis and clinical manifestation"},{"title3":"Dynamic innate immune responses of human bronchial epithelial cells to severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"SARS-associated coronavirus replication in cell lines"},{"title3":"  . Clinical Management of Severe Acute Respiratory Infection When Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection Is Suspected [Accessed 28 Aug 2017.] Available from URl: http://www.who.int/csr/disease/coronavirus_infections/case-management-ipc/en."},{"title3":"Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome"},{"title3":"The role of laboratory diagnostics in emerging viral infections: the example of the Middle East respiratory syndrome epidemic"},{"title3":"SARS: prognosis, outcome and sequelae"},{"title3":"Clinical epidemiology of bocavirus, rhinovirus, two polyomaviruses and four coronaviruses in HIV-infected and HIV-uninfected South African children"},{"title3":"A prospective hospital-based study of the clinical impact of non-severe acute respiratory syndrome (Non-SARS)-related human coronavirus infection"},{"title3":"Acute renal impairment in coronavirus-associated severe acute respiratory syndrome"},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Presentation and outcome of Middle East respiratory syndrome in Saudi intensive care unit patients"},{"title3":"Severe acute respiratory syndrome: radiographic appearances and pattern of progression in 138 patients"},{"title3":"Clinical presentation and outcomes of Middle East respiratory syndrome in the Republic of Korea"},{"title3":"Acute Middle East respiratory syndrome coronavirus: temporal lung changes observed on the chest radiographs of 55 patients"},{"title3":"CT correlation with outcomes in 15 patients with acute Middle East respiratory syndrome coronavirus"},{"title3":"Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines"},{"title3":"Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study"},{"title3":"Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study"},{"title3":"mRNA cap-1 methyltransferase in the SARS genome"},{"title3":"Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus"},{"title3":"Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"Treatment with lopinavir/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset"},{"title3":"Interferon-beta and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays"},{"title3":"The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis"},{"title3":"Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol"},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients"},{"title3":"Coronaviruses - drug discovery and therapeutic options"},{"title3":"Passive transfer of a germline-like neutralizing human monoclonal antibody protects transgenic mice against lethal Middle East respiratory syndrome coronavirus infection"},{"title3":"Blocking of exchange proteins directly activated by cAMP leads to reduced replication of Middle East respiratory syndrome coronavirus"},{"title3":"Inhibition of Middle East respiratory syndrome coronavirus infection by anti-CD26 monoclonal antibody"}]},{"title2":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome","References":[]},{"title2":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","References":[]},{"title2":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score","References":[]},{"title2":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus","References":[{"title3":"Severe acute respiratory syndrome"},{"title3":"Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003"},{"title3":"Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China"},{"title3":"Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS"},{"title3":"The Genome sequence of the SARS-associated coronavirus"},{"title3":"Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Prevalence and genetic diversity of coronaviruses in bats from China"},{"title3":"Intraspecies diversity of SARS-like coronaviruses in Rhinolophus sinicus and its implications for the origin of SARS coronaviruses in humans"},{"title3":"Identification of diverse alphacoronaviruses and genomic characterization of a novel severe acute respiratory syndrome-like coronavirus from bats in China"},{"title3":"Deciphering the bat virome catalog to better understand the ecological diversity of bat viruses and the bat origin of emerging infectious diseases"},{"title3":"Genomic characterization of severe acute respiratory syndrome-related coronavirus in European bats and classification of coronaviruses based on partial RNA-dependent RNA polymerase gene sequences"},{"title3":"Detection of novel SARS-like and other coronaviruses in bats from Kenya"},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor"},{"title3":"Isolation and Characterization of a Novel Bat Coronavirus Closely Related to the Direct Progenitor of Severe Acute Respiratory Syndrome Coronavirus"},{"title3":"SARS-like WIV1-CoV poised for human emergence"},{"title3":"Generic detection of coronaviruses and differentiation at the prototype strain level by reverse transcription-PCR and nonfluorescent low-density microarray"},{"title3":"Full-length genome sequences of two SARS-like coronaviruses in horseshoe bats and genetic variation analysis"},{"title3":"Severe Acute Respiratory Syndrome (SARS) Coronavirus ORF8 Protein Is Acquired from SARS-Related Coronavirus from Greater Horseshoe Bats through Recombination"},{"title3":"Bat Severe Acute Respiratory Syndrome-Like Coronavirus WIV1 Encodes an Extra Accessory Protein, ORFX, Involved in Modulation of the Host Immune Response"},{"title3":"Evidence for a common evolutionary origin of coronavirus spike protein receptor-binding subunits"},{"title3":"Ecoepidemiology and complete genome comparison of different strains of severe acute respiratory syndrome-related Rhinolophus bat coronavirus in China reveal bats as a reservoir for acute, self-limiting infection that allows recombination events"},{"title3":"The 29-nucleotide deletion present in human but not in animal severe acute respiratory syndrome coronaviruses disrupts the functional expression of open reading frame 8"},{"title3":"Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists"},{"title3":"Open reading frame 8a of the human severe acute respiratory syndrome coronavirus not only promotes viral replication but also induces apoptosis"},{"title3":"Novel SARS-like betacoronaviruses in bats, China, 2011"},{"title3":"ORF8-Related Genetic Evidence for Chinese Horseshoe Bats as the Source of Human Severe Acute Respiratory Syndrome Coronavirus"},{"title3":"Amplification of emerging viruses in a bat colony"},{"title3":"Longitudinal surveillance of SARS-like coronaviruses in bats by quantitative real-time PCR"},{"title3":"A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence"},{"title3":"Difference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin"},{"title3":"The 8ab protein of SARS-CoV is a luminal ER membrane-associated protein and induces the activation of ATF6"},{"title3":"Molecular determinants for subcellular localization of the severe acute respiratory syndrome coronavirus open reading frame 3b protein"},{"title3":"Bat severe acute respiratory syndrome-like coronavirus ORF3b homologues display different interferon antagonist activities"},{"title3":"Evolution of the cytochrome b gene of mammals"},{"title3":"Cryptic diversity in European bats"},{"title3":"Building phylogenetic trees from molecular data with MEGA"},{"title3":"RDP3: a flexible and fast computer program for analyzing recombination"},{"title3":"Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination"},{"title3":"New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0"}]},{"title2":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human","References":[]},{"title2":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation","References":[]},{"title2":"Evidence for camel-to-human transmission of MERS coronavirus","References":[]},{"title2":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history","References":[]},{"title2":"Origin and evolution of pathogenic coronaviruses","References":[{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Severe Acute Respiratory Syndrome (SARS) coronavirus ORF8 protein is acquired from SARS-related coronavirus from greater horseshoe bats through recombination"},{"title3":"SARS-CoV-2 and COVID-19: the most important research questions"},{"title3":"New insights into the mechanisms of RNA recombination"},{"title3":"Generation of coronavirus spike deletion variants by high-frequency recombination at regions of predicted RNA secondary structure"},{"title3":"RNA recombination in animal and plant viruses"},{"title3":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses"},{"title3":"Adaptive evolution of MERS-CoV to species variation in DPP4"},{"title3":"Bats and coronaviruses"}]},{"title2":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin","References":[{"title3":"Host and viral traits predict zoonotic spillover from mammals"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor"},{"title3":"Identification of diverse alphacoronaviruses and genomic characterization of a novel severe acute respiratory syndrome-like coronavirus from bats in China"},{"title3":"Isolation and characterization of a novel bat coronavirus closely related to the direct progenitor of severe acute respiratory syndrome coronavirus"},{"title3":"ORF8-related genetic evidence for Chinese horseshoe bats as the source of human severe acute respiratory syndrome coronavirus"},{"title3":"Discovery and genetic analysis of novel coronaviruses in least horseshoe bats in southwestern China"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"The genome sequence of the SARS-associated coronavirus"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Porcine deltacoronavirus in mainland China"},{"title3":"Epidemiology and vaccine of porcine epidemic diarrhea virus in China: a mini-review"},{"title3":"Complete genome sequence of bat coronavirus HKU2 from Chinese horseshoe bats revealed a much smaller spike gene with a different evolutionary lineage from the rest of the genome"},{"title3":"Molecular epidemiology of porcine epidemic diarrhea virus in China"},{"title3":"Serological diagnosis of human herpes simplex virus type 1 and 2 infections by luciferase immunoprecipitation system assay"},{"title3":"A new bat-HKU2-like coronavirus in swine, China, 2017"},{"title3":"Discovery of a novel swine enteric alphacoronavirus (SeACoV) in southern China"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Masters, P. S. &amp; Perlman, S. in Fields Virology Vol. 2 (eds Knipe, D. M. &amp; Howley, P. M.) 825-858 (Lippincott Williams &amp; Wilkins, Philadelphia, 2013)."},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"Difference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin"}]},{"title2":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission","References":[{"title3":"Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Evidence for a common evolutionary origin of coronavirus spike protein receptor-binding subunits"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"SWISSMODEL: an automated protein homology-modeling server"},{"title3":"GISAID: Global initiative on sharing all influenza data:from vision to reality"}]},{"title2":"Wuhan coronavirus has strong ability to infect humans. Press release","References":[]},{"title2":"From SARS to MERS, thrusting coronaviruses into the spotlight","References":[{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome"},{"title3":"Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor"},{"title3":"A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"SARS and MERS: Recent insights into emerging coronaviruses"},{"title3":"WHO Guidelines for the Global Surveillance of Severe Acute Respiratory Syndrome (SARS)"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"High Prevalence of MERS-CoV Infection in Camel Workers in Saudi Arabia"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: A descriptive study"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: A serologic, epidemiologic, and clinical description"},{"title3":"Response to Emergence of Middle East Respiratory Syndrome Coronavirus, Abu Dhabi, United Arab Emirates, 2013-2014"},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus"},{"title3":"An observational, laboratory-based study of outbreaks of middle East respiratory syndrome coronavirus in Jeddah and Riyadh, kingdom of Saudi Arabia, 2014"},{"title3":"Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015"},{"title3":"Severe acute respiratory syndrome (SARS): A year in review"},{"title3":"Coronaviruses: An overview of their replication and pathogenesis"},{"title3":"Current understanding of middle east respiratory syndrome coronavirus infection in human and animal models"},{"title3":"MERS-CoV spike protein: A key target for antivirals"},{"title3":"The spike protein of SARS-CoV:A target for vaccine and therapeutic development"},{"title3":"Middle East respiratory syndrome"},{"title3":"CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus"},{"title3":"Epithelial Cells Lining Salivary Gland Ducts Are Early Target Cells of Severe Acute Respiratory Syndrome Coronavirus Infection in the Upper Respiratory Tracts of Rhesus Macaques"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"The life cycle of SARS coronavirus in Vero E6 cells"},{"title3":"Pathogenetic mechanisms of severe acute respiratory syndrome"},{"title3":"Pathology and pathogenesis of severe acute respiratory syndrome"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: Implications for pathogenesis and virus transmission pathways"},{"title3":"Dipeptidyl Peptidase 4 Distribution in the Human Respiratory Tract: Implications for the Middle East Respiratory Syndrome"},{"title3":"Differential Expression of the Middle East Respiratory Syndrome Coronavirus Receptor in the Upper Respiratory Tracts of Humans and Dromedary Camels"},{"title3":"2014 MERS-CoV outbreak in Jeddah:A link to health care facilities"},{"title3":"Acute renal impairment in coronavirus-associated severe acute respiratory syndrome"},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: A single-center experience in Saudi Arabia"},{"title3":"Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia"},{"title3":"Dipeptidyl-peptidase IV from bench to bedside: An update on structural properties, functions, and clinical aspects of the enzyme DPP IV"},{"title3":"Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response"},{"title3":"Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: Implications for pathogenesis"},{"title3":"Middle East Respiratory Syndrome Coronavirus Efficiently Infects Human Primary T Lymphocytes and Activates the Extrinsic and Intrinsic Apoptosis Pathways"},{"title3":"MERS coronavirus induces apoptosis in kidney and lung by upregulating Smad7 and FGF2"},{"title3":"Protective T Cell Res.ponses Featured by Concordant Recognition of Middle East Respiratory Syndrome Coronavirus-Derived CD8+ T Cell Epitopes and Host MHC"},{"title3":"Tropism of and innate immune responses to the novel human betacoronavirus lineage C virus in human ex vivo respiratory organ cultures"},{"title3":"Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: Implications for pathogenesis and treatment"},{"title3":"The Genome sequence of the SARS-associated coronavirus"},{"title3":"Identification of two critical amino acid residues of the severe acute respiratory syndrome coronavirus spike protein for its variation in zoonotic tropism transition via a double substitution strategy"},{"title3":"Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"Receptor recognition mechanisms of coronaviruses: A decade of structural studies"},{"title3":"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26"},{"title3":"Structure of the fusion core and inhibition of fusion by a heptad repeat peptide derived from the S protein of Middle East respiratory syndrome coronavirus"},{"title3":"Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4"},{"title3":"Current advancements and potential strategies in the development of MERS-CoV vaccines"},{"title3":"Identification of a receptor-binding domain in the S protein of the novel human coronavirus Middle East respiratory syndrome coronavirus as an essential target for vaccine development"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Crystal structure of the receptor-binding domain from newly emerged Middle East respiratory syndrome coronavirus"},{"title3":"Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor"},{"title3":"Core structure of S2 from the human coronavirus NL63 spike glycoprotein"},{"title3":"Crystal structure of severe acute respiratory syndrome coronavirus spike protein fusion core"},{"title3":"Structural basis for coronavirus-mediated membrane fusion. Crystal structure of mouse hepatitis virus spike protein fusion core"},{"title3":"S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients"},{"title3":"SARS-associated coronavirus"},{"title3":"Conformational states of the severe acute respiratory syndrome coronavirus spike protein ectodomain"},{"title3":"A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2"},{"title3":"The SARS-CoV S glycoprotein: Expression and functional characterization"},{"title3":"A molecular docking model of SARS-CoV S1 protein in complex with its receptor, human ACE2"},{"title3":"A single amino acid substitution (R441A) in the receptor-binding domain of SARS coronavirus spike protein disrupts the antigenic structure and binding activity"},{"title3":"Identification and characterization of the putative fusion peptide of the severe acute respiratory syndrome-associated coronavirus spike protein"},{"title3":"pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN"},{"title3":"Specific asparagine-linked glycosylation sites are critical for DC-SIGN- and L-SIGN-mediated severe acute respiratory syndrome coronavirus entry"},{"title3":"A decade after SARS: Strategies for controlling emerging coronaviruses"},{"title3":"Amino acids 1055 to 1192 in the S2 region of severe acute respiratory syndrome coronavirus S protein induce neutralizing antibodies: Implications for the development of vaccines and antiviral agents"},{"title3":"An exposed domain in the severe acute respiratory syndrome coronavirus spike protein induces neutralizing antibodies"},{"title3":"Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS"},{"title3":"A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice"},{"title3":"Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcgammaRII-dependent entry into B cells in vitro"},{"title3":"Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets"},{"title3":"Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets"},{"title3":"Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants"},{"title3":"Evaluation of candidate vaccine approaches for MERS-CoV"},{"title3":"Rapid development of vaccines against emerging pathogens: The replication-deficient simian adenovirus platform technology"},{"title3":"Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB/c mice"},{"title3":"DNA vaccine encoding Middle East respiratory syndrome coronavirus S1 protein induces protective immune responses in mice"},{"title3":"Immunogenicity of Candidate MERS-CoV DNA Vaccines Based on the Spike Protein"},{"title3":"MERS-CoV vaccine candidates in development: The current landscape"},{"title3":"Airway Memory CD4+ T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses"},{"title3":"SARS vaccines: Where are we?"},{"title3":"Safety and immunogenicity from a phase I trial of inactivated severe acute respiratory syndrome coronavirus vaccine"},{"title3":"Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus"},{"title3":"Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus"},{"title3":"Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease"},{"title3":"A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge"},{"title3":"Effects of respiratory syncytial virus infection and major basic protein derived from eosinophils in pulmonary alveolar epithelial cells (A549)"},{"title3":"Complete protection against severe acute respiratory syndrome coronavirus-mediated lethal respiratory disease in aged mice by immunization with a mouse-adapted virus lacking E protein"},{"title3":"A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease"},{"title3":"Engineering a replication-competent, propagation-defective Middle East respiratory syndrome coronavirus as a vaccine candidate"},{"title3":"Engineering attenuated virus vaccines by controlling replication fidelity"},{"title3":"Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters"},{"title3":"Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants"},{"title3":"Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region"},{"title3":"Recombinant Receptor Binding Domain Protein Induces Partial Protective Immunity in Rhesus Macaques Against Middle East Respiratory Syndrome Coronavirus Challenge"},{"title3":"The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection"},{"title3":"Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein"},{"title3":"SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus"},{"title3":"The expression of membrane protein augments the specific responses induced by SARS-CoV nucleocapsid DNA immunization"},{"title3":"SARS coronavirus nucleocapsid immunodominant T-cell epitope cluster is common to both exogenous recombinant and endogenous DNA-encoded immunogens"},{"title3":"Procyanidins and butanol extract of Cinnamomi Cortex inhibit SARS-CoV infection"},{"title3":"Screening and identification of linear B-cell epitopes and entry-blocking peptide of severe acute respiratory syndrome (SARS)-associated coronavirus using synthetic overlapping peptide library"},{"title3":"Synthetic peptides outside the spike protein heptad repeat regions as potent inhibitors of SARS-associated coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides"},{"title3":"Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein"},{"title3":"Amino acid substitutions in the S2 subunit of mouse hepatitis virus variant V51 encode determinants of host range expansion"},{"title3":"Antigenic and immunogenic characterization of recombinant baculovirus-expressed severe acute respiratory syndrome coronavirus spike protein: Implication for vaccine design"},{"title3":"Cross-neutralization of human and palm civet severe acute respiratory syndrome coronaviruses by antibodies targeting the receptor-binding domain of spike protein"},{"title3":"Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: Importance for designing SARS vaccines"},{"title3":"Characterization of neutralizing monoclonal antibodies recognizing a 15-residues epitope on the spike protein HR2 region of severe acute respiratory syndrome coronavirus (SARS-CoV)"},{"title3":"Neutralizing antibodies in patients with severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"An efficient method to make human monoclonal antibodies from memory B cells: Potent neutralization of SARS coronavirus"},{"title3":"Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challenge"},{"title3":"Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies"},{"title3":"Generation and characterization of human monoclonal neutralizing antibodies with distinct binding and sequence features against SARS coronavirus using XenoMouse"},{"title3":"Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus"},{"title3":"Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association"},{"title3":"Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: Implications for virus fusogenic mechanism and identification of fusion inhibitors"},{"title3":"Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus"},{"title3":"A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein"},{"title3":"A conformation-dependent neutralizing monoclonal antibody specifically targeting receptor-binding domain in Middle East respiratory syndrome coronavirus spike protein"},{"title3":"Adenosine deaminase acts as a natural antagonist for dipeptidyl peptidase 4-mediated entry of the Middle East respiratory syndrome coronavirus"},{"title3":"Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)"},{"title3":"The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies"},{"title3":"Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2"},{"title3":"Protease inhibitors targeting coronavirus and filovirus entry"},{"title3":"Therapeutic Options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV)-possible lessons from a systematic review of SARS-CoV therapy"},{"title3":"Interferon-beta and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays"},{"title3":"Human monoclonal antibody combination against SARS coronavirus: Synergy and coverage of escape mutants"},{"title3":"A serological survey on neutralizing antibody titer of SARS convalescent sera"},{"title3":"Fully Human Monoclonal Antibody Directed to Proteolytic Cleavage Site in Severe Acute Respiratory Syndrome (SARS) Coronavirus S Protein Neutralizes the Virus in a Rhesus Macaque SARS Model"},{"title3":"Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-human Primates"},{"title3":"Human Neutralizing Monoclonal Antibody Inhibition of Middle East Respiratory Syndrome Coronavirus Replication in the Common Marmoset"},{"title3":"SARS: Systematic Review of Treatment Effects"},{"title3":"SARS: Clinical presentation, transmission, pathogenesis and treatment options"},{"title3":"Treatment with Lopinavir/Ritonavir or Interferon-beta1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset"},{"title3":"Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice"},{"title3":"Mice susceptible to SARS coronavirus"},{"title3":"Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice"},{"title3":"Mice transgenic for human angiotensin-converting enzyme 2 provide a model for SARS coronavirus infection"},{"title3":"Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans"},{"title3":"Resolution of primary severe acute respiratory syndrome-associated coronavirus infection requires Stat1"},{"title3":"Molecular determinants of severe acute respiratory syndrome coronavirus pathogenesis and virulence in young and aged mouse models of human disease"},{"title3":"Age-related increases in PGD(2) expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice"},{"title3":"T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice"},{"title3":"Evasion by stealth: Inefficient immune activation underlies poor T cell response and severe disease in SARS-CoV-infected mice"},{"title3":"MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV"},{"title3":"T cell responses to whole SARS coronavirus in humans"},{"title3":"Antibody response and viraemia during the course of severe acute respiratory syndrome (SARS)-associated coronavirus infection"},{"title3":"A double-inactivated whole virus candidate SARS coronavirus vaccine stimulates neutralising and protective antibody responses"},{"title3":"Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice"},{"title3":"Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine"},{"title3":"SARS vaccine protective in mice"},{"title3":"Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice"},{"title3":"An immunosuppressed Syrian golden hamster model for SARS-CoV infection"},{"title3":"Protection from infection with severe acute respiratory syndrome coronavirus in a Chinese hamster model by equine neutralizing F(ab')2"},{"title3":"Is there an ideal animal model for SARS?"},{"title3":"Therapy with a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syrian hamsters"},{"title3":"Virology: SARS virus infection of cats and ferrets"},{"title3":"Pathology of experimental SARS coronavirus infection in cats and ferrets"},{"title3":"Severe acute respiratory syndrome coronavirus infection in vaccinated ferrets"},{"title3":"Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets"},{"title3":"Severe acute respiratory syndrome vaccine efficacy in ferrets: Whole killed virus and adenovirus-vectored vaccines"},{"title3":"An animal model of SARS produced by infection of Macaca mulatta with SARS coronavirus"},{"title3":"Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys"},{"title3":"Macaque model for severe acute respiratory syndrome"},{"title3":"Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque"},{"title3":"Spatiotemporal interplay of severe acute respiratory syndrome coronavirus and respiratory mucosal cells drives viral dissemination in rhesus macaques"},{"title3":"Aetiology: Koch's postulates fulfilled for SARS virus"},{"title3":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome"},{"title3":"Pneumonitis and multi-organ system disease in common marmosets (Callithrix jacchus) infected with the severe acute respiratory syndrome-associated coronavirus"},{"title3":"Cynomolgus macaque as an animal model for severe acute respiratory syndrome"},{"title3":"Animal models for SARS"},{"title3":"Rhesus angiotensin converting enzyme 2 supports entry of severe acute respiratory syndrome coronavirus in Chinese macaques"},{"title3":"Mouse dipeptidyl peptidase 4 is not a functional receptor for Middle East respiratory syndrome coronavirus infection"},{"title3":"Wild-type and innate immune-deficient mice are not susceptible to the Middle East respiratory syndrome coronavirus"},{"title3":"Domestic Pig Unlikely Reservoir for MERS-CoV"},{"title3":"Permissivity of Dipeptidyl Peptidase 4 Orthologs to Middle East Respiratory Syndrome Coronavirus Is Governed by Glycosylation and Other Complex Determinants"},{"title3":"Asymptomatic Middle East respiratory syndrome coronavirus infection in rabbits"},{"title3":"The Middle East respiratory syndrome coronavirus (MERS-CoV) does not replicate in Syrian hamsters"},{"title3":"Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice"},{"title3":"Multi-Organ Damage in Human Dipeptidyl Peptidase 4 Transgenic Mice Infected with Middle East Respiratory Syndrome-Coronavirus"},{"title3":"Rapid generation of a mouse model for Middle East respiratory syndrome"},{"title3":"Severe acute respiratory syndrome coronavirus infection of mice transgenic for the human Angiotensin-converting enzyme 2 virus receptor"},{"title3":"A mouse model for MERS coronavirus-induced acute respiratory distress syndrome"},{"title3":"An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels"},{"title3":"Infection, Replication, and Transmission of Middle East Respiratory Syndrome Coronavirus in Alpacas"},{"title3":"Experimental Infection and Response to Rechallenge of Alpacas with Middle East Respiratory Syndrome Coronavirus"},{"title3":"An Animal Model of MERS Produced by Infection of Rhesus Macaques with MERS Coronavirus"},{"title3":"Comparative pathology of rhesus macaque and common marmoset animal models with Middle East respiratory syndrome coronavirus"},{"title3":"Infection with MERS-CoV causes lethal pneumonia in the common marmoset"},{"title3":"Pneumonia from human coronavirus in a macaque model"},{"title3":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques"},{"title3":"Intratracheal exposure of common marmosets to MERS-CoV Jordan-n3/2012 or MERS-CoV EMC/2012 isolates does not result in lethal disease"},{"title3":"Efficient replication of severe acute respiratory syndrome coronavirus in mouse cells is limited by murine angiotensin-converting enzyme 2"},{"title3":"Civets are equally susceptible to experimental infection by two different severe acute respiratory syndrome coronavirus isolates"},{"title3":"Receptor variation and susceptibility to Middle East respiratory syndrome coronavirus infection"},{"title3":"Host species restriction of Middle East respiratory syndrome coronavirus through its receptor, dipeptidyl peptidase 4"}]},{"title2":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis","References":[]},{"title2":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection","References":[{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Severe acute respiratory syndrome"},{"title3":"A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence"},{"title3":"Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia"},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore"},{"title3":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome"},{"title3":"Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome"},{"title3":"The Pathology and Pathogenesis of Experimental Severe Acute Respiratory Syndrome and Influenza in Animal Models"},{"title3":"The Immunobiology of SARS*"},{"title3":"Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: role of ciliated cells in viral spread in the conducting airways of the lungs"},{"title3":"Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice"},{"title3":"Age-related increases in PGD(2) expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice"},{"title3":"Molecular determinants of severe acute respiratory syndrome coronavirus pathogenesis and virulence in young and aged mouse models of human disease"},{"title3":"Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans"},{"title3":"Do men have a higher case fatality rate of severe acute respiratory syndrome than women do?"},{"title3":"SARS in Singapore--predictors of disease severity"},{"title3":"The pattern of Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive epidemiological analysis of data from the Saudi Ministry of Health"},{"title3":"Sex differences in immune responses"},{"title3":"Testosterone reduces macrophage expression in the mouse of toll-like receptor 4, a trigger for inflammation and innate immunity"},{"title3":"Sex-associated hormones and immunity to protozoan parasites"},{"title3":"Role of sex steroid hormones in bacterial-host interactions"},{"title3":"Sex hormones and the immune response in humans"},{"title3":"Sex differences in the recognition of and innate antiviral responses to Seoul virus in Norway rats"},{"title3":"Elevated 17beta-estradiol protects females from influenza A virus pathogenesis by suppressing inflammatory responses"},{"title3":"17beta-estradiol protects females against influenza by recruiting neutrophils and increasing virus-specific CD8 T cell responses in the lungs"},{"title3":"CD200 receptor controls sex-specific TLR7 responses to viral infection"},{"title3":"Sex chromosome complement contributes to sex differences in coxsackievirus B3 but not influenza A virus pathogenesis"},{"title3":"The complex role of estrogens in inflammation"},{"title3":"The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men"},{"title3":"Estrogenic compounds reduce influenza A virus replication in primary human nasal epithelial cells derived from female, but not male, donors"},{"title3":"Type I interferon is a therapeutic target for virus-induced lethal vascular damage"},{"title3":"Tamoxifen administration to mice"},{"title3":"Age-dependent dysregulation of innate immunity"},{"title3":"Implications of X-linked gene regulation for sex differences in disease pathogenesis (comment on DOI 10.1002/bies.201100047)"},{"title3":"The effects of hormones on sex differences in infection: from genes to behavior"},{"title3":"Chromosome mapping of Rmp-4, a gonad-dependent gene encoding host resistance to mousepox"},{"title3":"Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1"},{"title3":"The TLR-mediated response of plasmacytoid dendritic cells is positively regulated by estradiol in vivo through cell-intrinsic estrogen receptor alpha signaling"},{"title3":"Estradiol suppresses NF-kappa B activation through coordinated regulation of let-7a and miR-125b in primary human macrophages"},{"title3":"Estrogen inhibits lipopolysaccharide-induced tumor necrosis factor-alpha release from murine macrophages"},{"title3":"A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice"},{"title3":"Female gender, estrogen loss, and Sub-RPE deposit formation in aged mice"},{"title3":"Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8"}]},{"title2":"Sexual dimorphism in innate immunity","References":[{"title3":"Overview of the immune response"},{"title3":"Genetic influence on inflammation variables in the elderly"},{"title3":"C-reactive protein, an 'intermediate phenotype' for inflammation: human twin studies reveal heritability, association with blood pressure and the metabolic syndrome, and the influence of common polymorphism at catecholaminergic/beta-adrenergic pathway loci"},{"title3":"Trained immunity: A program of innate immune memory in health and disease"},{"title3":"Defining trained immunity and its role in health and disease"},{"title3":"Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes"},{"title3":"Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes"},{"title3":"Glutaminolysis and Fumarate Accumulation Integrate Immunometabolic and Epigenetic Programs in Trained Immunity"},{"title3":"Metabolic Induction of Trained Immunity through the Mevalonate Pathway"},{"title3":"Heme induces innate immune memory"},{"title3":"Host and Environmental Factors Influencing Individual Human Cytokine Responses"},{"title3":"Sex-differences in the prevalence of Helicobacter pylori infection in pediatric and adult populations: Systematic review and meta-analysis of 244 studies"},{"title3":"Sexual inequality in tuberculosis"},{"title3":"Gender disparity in infections of Hepatitis B virus"},{"title3":"Sexual Dimorphism in Innate Immunity"},{"title3":"OpenSAFELY: factors associated with COVID-19 death in 17 million patients"},{"title3":"The Xs and Y of immune responses to viral vaccines"},{"title3":"An immune clock of human pregnancy"},{"title3":"Trained Memory of Human Uterine NK Cells Enhances Their Function in Subsequent Pregnancies"},{"title3":"Sex hormones and the immune response in humans"},{"title3":"Signaling by nuclear receptors"},{"title3":"Rapid steroid hormone actions via membrane receptors"},{"title3":"Sex steroid receptors in immune cells"},{"title3":"Differential estrogen receptor gene expression in human peripheral blood mononuclear cell populations"},{"title3":"X-chromosome complement and estrogen receptor signaling independently contribute to the enhanced TLR7-mediated IFN-alpha production of plasmacytoid dendritic cells from women"},{"title3":"The TLR-mediated response of plasmacytoid dendritic cells is positively regulated by estradiol in vivo through cell-intrinsic estrogen receptor alpha signaling"},{"title3":"Estrogen action and cytoplasmic signaling pathways. Part II: the role of growth factors and phosphorylation in estrogen signaling"},{"title3":"Estrogen receptors regulate innate immune cells and signaling pathways"},{"title3":"The Immune System Is a Natural Target for Estrogen Action: Opposing Effects of Estrogen in Two Prototypical Autoimmune Diseases"},{"title3":"Identification of pathway-selective estrogen receptor ligands that inhibit NF-kappaB transcriptional activity"},{"title3":"The estrogen metabolite 17beta-dihydroequilenin counteracts interleukin-1alpha induced expression of inflammatory mediators in human endothelial cells in vitro via NF-kappaB pathway"},{"title3":"Reciprocal antagonism between estrogen receptor and NF-kappaB activity in vivo"},{"title3":"CBP Is a dosage-dependent regulator of nuclear factor-kappaB suppression by the estrogen receptor"},{"title3":"Estrogen anti-inflammatory activity on human monocytes is mediated through cross-talk between estrogen receptor ERalpha36 and GPR30/GPER1"},{"title3":"NF-kappaB signaling in inflammation"},{"title3":"Nuclear Factor-kappaB in Autoimmunity: Man and Mouse"},{"title3":"The potential influence of breast cancer estrogen receptors' distribution on active DNA demethylation"},{"title3":"Membrane progesterone receptor beta (mPRbeta/Paqr8) promotes progesterone-dependent neurite outgrowth in PC12 neuronal cells via non-G protein-coupled receptor (GPCR) signaling"},{"title3":"Estrogen and progesterone receptor expression in macrophages and regulation of hepatocyte growth factor by ovarian steroids in women with endometriosis"},{"title3":"Progesterone-based compounds affect immune responses and susceptibility to infections at diverse mucosal sites"},{"title3":"Inhibitory effects of progesterone differ in dendritic cells from female and male rodents"},{"title3":"Pregnancy and pregnancy-associated hormones alter immune responses and disease pathogenesis"},{"title3":"Differential Modulation of TLR3- and TLR4-Mediated Dendritic Cell Maturation and Function by Progesterone"},{"title3":"Toll-like receptor-4-mediated macrophage activation is differentially regulated by progesterone via the glucocorticoid and progesterone receptors"},{"title3":"Androgen Receptor Structure, Function and Biology: From Bench to Bedside"},{"title3":"Androgen-Induced Immunosuppression"},{"title3":"Testosterone suppresses phospholipase D, causing sex differences in leukotriene biosynthesis in human monocytes"},{"title3":"[17beta-Estradiol and testosterone influence the mRNA expression and the time course of inflammatory cytokines in activated human monocytic cell line (THP-1)]"},{"title3":"Testosterone Reduces Macrophage Expression in the Mouse of Toll-Like Receptor 4, a Trigger for Inflammation and Innate Immunity"},{"title3":"The effect of testosterone on cytokine production in the specific and non-specific immune response"},{"title3":"The impact of sex hormones on BCG-induced trained immunity"},{"title3":"The role of circulating sex hormones in menstrual cycle-dependent modulation of pain-related brain activation"},{"title3":"The complex role of estrogens in inflammation"},{"title3":"Estradiol down-regulates LPS-induced cytokine production and NFkB activation in murine macrophages"},{"title3":"Gonadal steroids modulate human monocyte interleukin-1 (IL-1) activity"},{"title3":"The inducible expression of THP-1 cell interleukin-1 mRNA: Effects of estrogen on differential response to phorbol ester and lipopolysaccharide"},{"title3":"Neutrophil extracellular traps: double-edged swords of innate immunity"},{"title3":"Sex-specific alterations in neutrophil apoptosis: the role of estradiol and progesterone"},{"title3":"Estrogen Modulates Inflammatory Mediator Expression and Neutrophil Chemotaxis in Injured Arteries"},{"title3":"Estrogens Augment Cell Surface TLR4 Expression on Murine Macrophages and Regulate Sepsis Susceptibility in Vivo"},{"title3":"Sexual dimorphism in bacterial infections"},{"title3":"Association of Sex With Clinical Outcome in Critically Ill Sepsis Patients: A Retrospective Analysis of the Large Clinical Database MIMIC-III"},{"title3":"Progesterone-Related Immune Modulation of Pregnancy and Labor"},{"title3":"Multimodal Regulation of NET Formation in Pregnancy: Progesterone Antagonizes the Pro-NETotic Effect of Estrogen and G-CSF"},{"title3":"Selective inhibition and augmentation of alternative macrophage activation by progesterone"},{"title3":"Progesterone rapidly down-regulates the biosynthesis of 5-lipoxygenase products in human primary monocytes"},{"title3":"The Role of Monocytes and Macrophages in Autoimmune Diseases: A Comprehensive Review"},{"title3":"Chapter 11 - Role of Macrophages in Autoimmunity"},{"title3":"Sexual dimorphism in autoimmunity"},{"title3":"Epidemiology and estimated population burden of selected autoimmune diseases in the United States"},{"title3":"Autoimmune Disease in Women: Endocrine Transition and Risk Across the Lifespan"},{"title3":"How does age at onset influence the outcome of autoimmune diseases"},{"title3":"Autoimmune diseases and reproductive aging"},{"title3":"Estrogen receptor-alpha deficiency attenuates autoimmune disease in (NZB x NZW)F1 mice"},{"title3":"Suppression of the inflammatory response in experimental arthritis is mediated via estrogen receptor alpha but not estrogen receptor beta"},{"title3":"Treatment with an Estrogen Receptor alpha Ligand Is Neuroprotective in Experimental Autoimmune Encephalomyelitis"},{"title3":"The Anti-Inflammatory Effects of Testosterone"},{"title3":"Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice"},{"title3":"Effect of Castration on the Appearance of Diabetes in NOD Mouse"},{"title3":"A Protective Role For Testosterone In Adjuvant-Induced Arthritis"},{"title3":"Testosterone inhibits immunoglobulin production by human peripheral blood mononuclear cells"},{"title3":"Testosterone suppresses anti-DNA antibody production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus"},{"title3":"Prolonged hypogonadism in male patients with rheumatoid arthritis during flares in disease activity"},{"title3":"Sex hormone status of male patients with rheumatoid arthritis: evidence of low serum concentrations of testosterone at baseline and after human chorionic gonadotropin stimulation"},{"title3":"Free and serum testosterone levels in 276 males: a comparative study of rheumatoid arthritis, ankylosing spondylitis and healthy controls"},{"title3":"Decreased testosterone levels in men with rheumatoid arthritis: effect of low dose prednisone therapy"},{"title3":"Hormonal and pregnancy relationships to rheumatoid arthritis: convergent effects with immunologic and microvascular systems"},{"title3":"Adrenocorticotropin, glucocorticoid, and androgen secretion in patients with new onset synovitis/rheumatoid arthritis: relations with indices of inflammation"},{"title3":"Gonadal hormones in men with rheumatoid arthritis-from onset through 2 years"},{"title3":"Bioavailable testosterone in men with rheumatoid arthritis-high frequency of hypogonadism"},{"title3":"High frequency of association of rheumatic/autoimmune diseases and untreated male hypogonadism with severe testicular dysfunction"},{"title3":"Systemic lupus erythematosus in men. Genetic and endocrine features"},{"title3":"Abnormalities of sex hormones in men with systemic lupus erythematosus"},{"title3":"Plasma sex hormones and aromatase activity in tissues of patients with systemic lupus erythematosus"},{"title3":"Systemic lupus erythematosus: sex hormones in male patients"},{"title3":"Evaluation of the hypothalamic-pituitary-gonadal axis in males with systemic lupus erythematosus"},{"title3":"Hormonal profiles and immunological studies of male lupus in Taiwan"},{"title3":"Profile of sex hormones in male patients with systemic lupus erythematosus"},{"title3":"Bone mineral density, biochemical markers of bone turnover, and hormonal status in men with systemic lupus erythematosus"},{"title3":"Penile anthropometry in systemic lupus erythematosus patients"},{"title3":"The neuroendocrine axis in patients with multiple sclerosis"},{"title3":"Evaluation of endocrine profile, hypothalamic-pituitary-testis axis and semen quality in multiple sclerosis"},{"title3":"Hypogonadism and the risk of rheumatic autoimmune disease"},{"title3":"A Higher Ratio of Estradiol to Testosterone Is Associated with Autoimmune Thyroid Disease in Males"},{"title3":"The relationship between circulating estradiol and thyroid autoimmunity in males"},{"title3":"Estradiol levels are elevated in older men with diffuse cutaneous SSc and are associated with decreased survival"},{"title3":"Sex Differences in the Blood Transcriptome Identify Robust Changes in Immune Cell Proportions with Aging and Influenza Infection"},{"title3":"Sex differences in the human peripheral blood transcriptome"},{"title3":"ImmGen report: sexual dimorphism in the immune system transcriptome"},{"title3":"Integrative analysis of methylome and transcriptome in human blood identifies extensive sex-and immune cell-specific differentially methylated regions"},{"title3":"Adaptation and memory in immune responses"},{"title3":"Perceptions of epigenetics"},{"title3":"Latent enhancers activated by stimulation in differentiated cells"},{"title3":"Transcriptional and epigenetic regulation of macrophages in atherosclerosis"},{"title3":"beta-Glucan Reverses the Epigenetic State of LPS-Induced Immunological Tolerance"},{"title3":"Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity"},{"title3":"Human monocyte-to-macrophage differentiation involves highly localized gain and loss of DNA methylation at transcription factor binding sites"},{"title3":"Extensive epigenomic integration of the glucocorticoid response in primary human monocytes and in vitro derived macrophages"},{"title3":"Epigenetics of estrogen receptor signaling: role in hormonal cancer progression and therapy"},{"title3":"Steroid hormones regulate genome-wide epigenetic programming and gene transcription in human endometrial cells with marked aberrancies in endometriosis"},{"title3":"Global DNA methylation changes spanning puberty are near predicted estrogen-responsive genes and enriched for genes involved in endocrine and immune processes"},{"title3":"Pubertal development in healthy children is mirrored by DNA methylation patterns in peripheral blood"},{"title3":"DNA Methylation Trajectories During Pregnancy"},{"title3":"The Cellular Transcriptome in the Maternal Circulation During Normal Pregnancy: A Longitudinal Study"},{"title3":"Longitudinal profiling of human blood transcriptome in healthy and lupus pregnancy"},{"title3":"Transient epigenomic changes during pregnancy and early postpartum in women with and without type 2 diabetes"},{"title3":"Effect of Menopause on Gene Expression Profiles of Circulating Monocytes: A Pilot in vivo Microarray Study"},{"title3":"Hormone Replacement Therapy Associated White Blood Cell DNA Methylation and Gene Expression are Associated With Within-Pair Differences of Body Adiposity and Bone Mass"},{"title3":"Effects of Ageing on the Immune System: Infants to Elderly"},{"title3":"T-cell subsets in healthy teenagers: Transition to the adult phenotype"},{"title3":"Immune Function in Healthy Adolescents"},{"title3":"Hormones in pregnancy"},{"title3":"Human Chorionic Gonadotropin as a Pivotal Endocrine Immune Regulator Initiating and Preserving Fetal Tolerance"},{"title3":"Mechanism of human chorionic gonadotrophin-mediated immunomodulation in pregnancy"},{"title3":"Shifts in the TH1/TH2 Balance during Human Pregnancy Correlate with Apoptotic Changes"},{"title3":"The Th1:th2 dichotomy of pregnancy and preterm labour"},{"title3":"Modulations of Cytokine Expression in Pregnant Women"},{"title3":"The Role of Extracellular Vesicles and PIBF in Embryo-Maternal Immune-Interactions"},{"title3":"Th1 and Th2 cytokine profiles in recurrent aborters with successful pregnancy and with subsequent abortions"},{"title3":"Pregnancy-specific down-regulation of NF-kappa B expression in T cells in humans is essential for the maintenance of the cytokine profile required for pregnancy success"},{"title3":"The pro-inflammatory and anti-inflammatory cytokine profile in peripheral blood of women with recurrent implantation failure"},{"title3":"Regulatory T cells mediate maternal tolerance to the fetus"},{"title3":"Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset"},{"title3":"Regulatory T cells are necessary for implantation and maintenance of early pregnancy but not late pregnancy in allogeneic mice"},{"title3":"Influence of reproductive hormones on the induction of CD4(+)CD25 (bright)Foxp (3+) regulatory T cells"},{"title3":"Immune Modulatory Effects of Human Chorionic Gonadotropin on Dendritic Cells Supporting Fetal Survival in Murine Pregnancy"},{"title3":"Human chorionic gonadotropin attracts regulatory T cells into the fetal-maternal interface during early human pregnancy"},{"title3":"Human Chorionic Gonadotropin modulates CXCL10 Expression through Histone Methylation in human decidua"},{"title3":"The contribution of macrophages to normal and pathological pregnancies"},{"title3":"Gene Expression Profiling of Human Decidual Macrophages: Evidence for Immunosuppressive Phenotype"},{"title3":"In-depth characterization of monocyte subsets during the course of healthy pregnancy"},{"title3":"Innate immune responses to toll-like receptor stimulation are altered during the course of pregnancy"},{"title3":"Endotoxin-induced cytokine production of monocytes of third-trimester pregnant women compared with women in the follicular phase of the menstrual cycle"},{"title3":"The first trimester gravid serum regulates procalcitonin expression in human macrophages skewing their phenotype in vitro"},{"title3":"Estrogen-dependent regulation of human uterine natural killer cells promotes vascular remodelling via secretion of CCL2"},{"title3":"The uterine NK cell population requires IL-15 but these cells are not required for pregnancy nor the resolution of a Listeria monocytogenes infection"},{"title3":"Progesterone Enhances Interleukin-15 Production in Human Endometrial Stromal Cells in Vitro1"},{"title3":"The remission of rheumatoid arthritis during pregnancy"},{"title3":"Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group"},{"title3":"Immunity, thyroid function and pregnancy: molecular mechanisms"},{"title3":"How pregnancy can affect autoimmune diseases progression"},{"title3":"Obstetric outcome in systemic lupus erythematosus"},{"title3":"Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies"},{"title3":"Estradiol-17beta-Induced Changes in the Porcine Endometrial Transcriptome In Vivo"},{"title3":"The maternal plasma proteome changes as a function of gestational age in normal pregnancy: a longitudinal study"},{"title3":"Reproductive hormones and the menopause transition"},{"title3":"Effects of Sex Hormones and Age on Brain Volume in Post-Menopausal Women"},{"title3":"Hormone replacement therapy and the prevention of postmenopausal osteoporosis"},{"title3":"Global gene expression profiles in skeletal muscle of monozygotic female twins discordant for hormone replacement therapy"},{"title3":"Identification of an Epigenetic Signature of Osteoporosis in Blood DNA of Postmenopausal Women"},{"title3":"Distinct DNA methylation profiles in bone and blood of osteoporotic and healthy postmenopausal women"},{"title3":"The relationship between testosterone and molecular markers of inflammation in older men"},{"title3":"Inflammaging: a new immune-metabolic viewpoint for age-related diseases"},{"title3":"Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination"},{"title3":"Hormone therapy for trans and gender diverse patients in the general practice setting"},{"title3":"Changes in regional body fat, lean body mass and body shape in trans persons using cross-sex hormonal therapy: results from a multicenter prospective study"},{"title3":"What does the &quot;four core genotypes&quot; mouse model tell us about sex differences in the brain and other tissues"},{"title3":"A primer on the use of mouse models for identifying direct sex chromosome effects that cause sex differences in non-gonadal tissues"},{"title3":"The number of x chromosomes causes sex differences in adiposity in mice"},{"title3":"Sex differences in diurnal rhythms of food intake in mice caused by gonadal hormones and complement of sex chromosomes"},{"title3":"Significant symptomatic improvement of subacute cutaneous lupus after testosterone therapy in a female-to-male transgender subject"},{"title3":"Lupus erythematosus tumidus induced by sex reassignment surgery"},{"title3":"Development of systemic lupus erythematosus in a male-to-female transsexual: the role of sex hormones revisited"},{"title3":"New-onset lupus nephritis after male-to-female sex reassignment surgery"},{"title3":"Effects of sex steroids on the pattern of methylation and expression of the promoter region of estrogen and androgen receptors in people with gender dysphoria under cross-sex hormone treatment"},{"title3":"Transgender Women on Feminizing Hormone Therapy Demonstrate a Distinct Rectal Mucosal Transcriptome from Cisgender Men"},{"title3":"BCG vaccination in humans inhibits systemic inflammation in a sex-dependent manner"},{"title3":"Personalized vaccinology: one size and dose might not fit both sexes"}]},{"title2":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections","References":[]},{"title2":"Clinical findings in 111 cases of influenza A (H7N9) virus infection","References":[]},{"title2":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai","References":[{"title3":"Human infection with a novel avian-origin influenza A (H7N9) virus. N human infection with a novel avian-origin influenza A (H7N9) virus"},{"title3":"Influenza viruses: from birds to humans"},{"title3":"Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome"},{"title3":"Genetic analysis of novel avian A(H7N9) influenza viruses isolated from patients in China, February to April 2013"},{"title3":"Family outbreak of severe pneumonia induced by H7N9 infection"},{"title3":"Probable person to person transmission of novel avian influenza A (H7N9) virus in Eastern China, 2013: epidemiological investigation"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators. Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome"},{"title3":"Body mass index is associated with the development of acute respiratory distress syndrome"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Determinants of antiviral effectiveness in influenza virus A subtype H5N1"},{"title3":"Risk factors for mortality in patients with nosocomial Gram-negative rod bacteremia"},{"title3":"Glucocorticoid treatment in acute lung injury and acute respiratory distress syndrome"},{"title3":"What caused lymphopenia in SARS and how reliable is the lymphokine status in glucocorticoid-treated patients?"},{"title3":"What is the role of steroids in pneumonia therapy?"},{"title3":"Clinical analysis of complications after non- invasive positive pressure ventilation and an inquiry into the respiratory treatment strategy in patients with SARS"},{"title3":"Evolution of pulmonary pathology in severe acute respiratory syndrome"}]},{"title2":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV","References":[{"title3":"Evaluation of serologic and antigenic relationships between Middle Eastern respiratory syndrome coronavirus and other coronaviruses to develop vaccine platforms for the rapid response to emerging coronaviruses"},{"title3":"DNA vaccination: transfection and activation of dendritic cells as key events for immunity"},{"title3":"Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description"},{"title3":"Antibody response and disease severity in healthcare worker MERS survivors"},{"title3":"Feasibility of using convalescent plasma immunotherapy for MERS-CoV infection, Saudi Arabia"},{"title3":"High-resolution structure of HLA-A*1101 in complex with SARS nucleocapsid peptide"},{"title3":"Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome"},{"title3":"Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests"},{"title3":"Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice"},{"title3":"Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection"},{"title3":"Response of memory CD8+ T cells to severe acute respiratory syndrome (SARS) coronavirus in recovered SARS patients and healthy individuals"},{"title3":"Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection"},{"title3":"SARS coronavirus papain-like protease inhibits the type I interferon signaling pathway through interaction with the STING-TRAF3-TBK1 complex"},{"title3":"Identification of SARS-COV spike protein-derived and HLA-A2-restricted human CTL epitopes by using a new muramyl dipeptidederivative adjuvant"},{"title3":"Induction of T-cell response by a DNA vaccine encoding a novel HLA-A*0201 severe acute respiratory syndrome coronavirus epitope"},{"title3":"Middle East respiratory syndrome coronavirus efficiently infects human primary T Lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"Rooting the phylogenetic tree of Middle East respiratory syndrome coronavirus by characterization of a conspecific virus from an African bat"},{"title3":"Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus"},{"title3":"Characteristics of traveler with Middle East respiratory syndrome, China, 2015"},{"title3":"The HLA-A2-supermotif: a QSAR definition"},{"title3":"The spike protein of SARS-CoV-a target for vaccine and therapeutic development"},{"title3":"Antibodies induced by receptor-binding domain in spike protein of SARS-CoV do not cross-neutralize the novel human coronavirus hCoV-EMC"},{"title3":"Vaccines for the prevention against the threat of MERS-CoV"},{"title3":"A 219-mer CHO-expressing receptor-binding domain of SARS-CoV S protein induces potent immune responses and protective immunity"},{"title3":"Antigenicity and immunogenicity of SARS-CoV S protein receptor-binding domain stably expressed in CHO cells"},{"title3":"Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection"},{"title3":"Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection"},{"title3":"Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?"},{"title3":"Towards our understanding of SARS-CoV, an emerging and devastating but quickly conquered virus"},{"title3":"SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Identification of immunodominant epitopes on the membrane protein of the severe acute respiratory syndrome-associated coronavirus"},{"title3":"Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation"},{"title3":"From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses"},{"title3":"Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus"},{"title3":"Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4+ and CD8+ T cells promote cellular immune responses"},{"title3":"Improved transgenic mouse model for studying HLA class I antigen presentation"},{"title3":"Identification of residues of SARS-CoV nsp1 that differentially affect inhibition of gene expression and antiviral signaling"},{"title3":"Structural insights into key sites of vulnerability on HIV-1 Env and influenza HA"},{"title3":"Clinical and laboratory findings of the first imported case of Middle East respiratory syndrome coronavirus to the United States"},{"title3":"Efficient induction of cytotoxic T lymphocytes specific for severe acute respiratory syndrome (SARS)-associated coronavirus by immunization with surface-linked liposomal peptides derived from a non-structural polyprotein 1a"},{"title3":"Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Tailoring subunit vaccine immunity with adjuvant combinations and delivery routes using the Middle East respiratory coronavirus (MERS-CoV) receptor-binding domain as an antigen"},{"title3":"Genetic characterization of Betacoronavirus lineage C viruses in bats reveals marked sequence divergence in the spike protein of pipistrellus bat coronavirus HKU5 in Japanese pipistrelle: implications for the origin of the novel Middle East respiratory syndrome coronavirus"},{"title3":"Immunopathology of mouse hepatitis virus type 3 infection. Role of humoral and cell-mediated immunity in resistance mechanisms"},{"title3":"Antibody response of patients with severe acute respiratory syndrome (SARS) targets the viral nucleocapsid"},{"title3":"T cell responses to whole SARS coronavirus in humans"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"Recombinant duck enteritis viruses expressing major structural proteins of the infectious bronchitis virus provide protection against infectious bronchitis in chickens"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein"},{"title3":"Identification of an epitope of SARS-coronavirus nucleocapsid protein"},{"title3":"Functional and structural definition of a clustering region of HLA-A2-restricted cytotoxic T lymphocyte epitopes"},{"title3":"The membrane protein of severe acute respiratory syndrome coronavirus acts as a dominant immunogen revealed by a clustering region of novel functionally and structurally defined cytotoxic T-lymphocyte epitopes"},{"title3":"Novel immunodominant peptide presentation strategy: a featured HLA-A*2402-restricted cytotoxic T-lymphocyte epitope stabilized by intrachain hydrogen bonds from severe acute respiratory syndrome coronavirus nucleocapsid protein"},{"title3":"Revival of the identification of cytotoxic T-lymphocyte epitopes for immunological diagnosis, therapy and vaccine development"},{"title3":"Characterization of human alphabetaTCR repertoire and discovery of D-D fusion in TCRbeta chains"},{"title3":"Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome"},{"title3":"Protective T-cell responses featured by concordant recognition of MERS-CoV-derived CD8+ T-cell epitopes and host MHC"},{"title3":"Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV"},{"title3":"Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoV"},{"title3":"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26"},{"title3":"Bat-to-human: spike features determining 'host jump' of coronaviruses SARS-CoV, MERS-CoV, and beyond"},{"title3":"Identification of a novel conserved HLA-A*0201-restricted epitope from the spike protein of SARS-CoV"},{"title3":"Priming of CD8+ T cells during central nervous system infection with a murine coronavirus is strain dependent"},{"title3":"A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial"},{"title3":"Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-o-methyltransferase activity"},{"title3":"Serological assays for emerging coronaviruses: challenges and pitfalls"},{"title3":"Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity"},{"title3":"The structure and function of CD26 in the T-cell immune response"},{"title3":"Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection"},{"title3":"Middle East respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist"},{"title3":"Engineering T cells specific for a dominant severe acute respiratory syndrome coronavirus CD8 T cell epitope"},{"title3":"Synthetic peptides coupled to the surface of liposomes effectively induce SARS coronavirus-specific cytotoxic T lymphocytes and viral clearance in HLA-A*0201 transgenic mice"},{"title3":"Kinetics of serologic responses to MERS coronavirus infection in humans, South Korea"},{"title3":"Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients"},{"title3":"Characterization of cytotoxic T-lymphocyte epitopes and immune responses to SARS coronavirus spike DNA vaccine expressing the RGD-integrin-binding motif"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"Specific serology for emerging human coronaviruses by protein microarray"},{"title3":"Geographic distribution of MERS coronavirus among dromedary camels, Africa"},{"title3":"Defining CD8+ T cell determinants during human viral infection in populations of Asian ethnicity"},{"title3":"Structure of a SARS coronavirus-derived peptide bound to the human major histocompatibility complex class I molecule HLA-B*1501"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"A comprehensive comparison of transmembrane domains reveals organelle-specific properties"},{"title3":"Mouse hepatitis virus-specific cytotoxic T lymphocytes protect from lethal infection without eliminating virus from the central nervous system"},{"title3":"MERS in South Korea and China: a potential outbreak threat?"},{"title3":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses"},{"title3":"A new unconventional HLA-A2-restricted epitope from HBV core protein elicits antiviral cytotoxic T lymphocytes"},{"title3":"Evaluation of protective efficacy of the synthetic peptide vaccine containing the T-helper 1 epitope with CpG oligodeoxynucleotide against feline infectious peritonitis virus infection in cats"},{"title3":"Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study"},{"title3":"Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution"},{"title3":"From SARS coronavirus to novel animal and human coronaviruses"},{"title3":"Structural and functional correlates of enhanced antiviral immunity generated by heteroclitic CD8 T cell epitopes"},{"title3":"HLA-A*0201 T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus nucleocapsid and spike proteins"},{"title3":"Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus"},{"title3":"Middle East respiratory syndrome and severe acute respiratory syndrome"},{"title3":"Protective efficacy of recombinant modified vaccinia virus ankara delivering Middle East respiratory syndrome coronavirus spike glycoprotein"},{"title3":"Identification of an HLA-A*0201-restricted CD8(+) T-cell epitope SSp-1 of SARS-CoV spike protein"},{"title3":"Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26"},{"title3":"MERS-CoV spike protein: targets for vaccines and therapeutics"},{"title3":"Serological study of an imported case of Middle East respiratory syndrome and his close contacts in China, 2015"},{"title3":"Origin and possible genetic recombination of the Middle East respiratory syndrome coronavirus from the first imported case in China: phylogenetics and coalescence analysis"},{"title3":"T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus spike protein elicit a specific T-cell immune response in patients who recover from SARS"},{"title3":"MERS, SARS, and Ebola: the role of super-spreaders in infectious disease"},{"title3":"Detection of specific antibodies to severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein for serodiagnosis of SARS coronavirus pneumonia"},{"title3":"Immune responses to T-cell epitopes of SARS CoV-N protein are enhanced by N immunization with a chimera of lysosome-associated membrane protein"},{"title3":"Persistent memory CD4+ and CD8+ T-cell responses in recovered severe acute respiratory syndrome (SARS) patients to SARS coronavirus M antigen"},{"title3":"Long-lived effector/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients"},{"title3":"Middle East respiratory syndrome coronavirus ORF4b protein inhibits type I interferon production through both cytoplasmic and nuclear targets"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Current advancements and potential strategies in the development of MERS-CoV vaccines"},{"title3":"Frequency, private specificity, and cross-reactivity of preexisting hepatitis C virus (HCV)-Specific CD8+ T cells in HCV-seronegative individuals: implications for vaccine responses"},{"title3":"Identification and characterization of dominant helper T-cell epitopes in the nucleocapsid protein of severe acute respiratory syndrome coronavirus"},{"title3":"Passive immunotherapy with dromedary immune serum in an experimental animal model for Middle East respiratory syndrome coronavirus infection"},{"title3":"Airway memory CD4(+) T cells mediate protective immunity against emerging respiratory coronaviruses"},{"title3":"T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice"},{"title3":"The immune responses of HLA-A*0201 restricted SARS-CoV S peptide-specific CD8(+) T cells are augmented in varying degrees by CpG ODN, PolyI: C and R848"},{"title3":"CD8+ T cell response in HLA-A*0201 transgenic mice is elicited by epitopes from SARS-CoV S protein"},{"title3":"Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein"},{"title3":"Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis"},{"title3":"Screening and identification of severe acute respiratory syndrome-associated coronavirus-specific CTL epitopes"},{"title3":"Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01"},{"title3":"Coronavirus non-structural protein 1 is a major pathogenicity factor: implications for the rational design of coronavirus vaccines"}]}]},{"title1":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study","References":[{"title2":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome","References":[]},{"title2":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","References":[]},{"title2":"A Novel Coronavirus from Patients with Pneumonia in China, 2019","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Inferring the hosts of coronavirus using dual statistical models based on nucleotide composition"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"2019 novel coronavirus (2019-nCoV) outbreak: a new challenge"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan"},{"title3":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China"},{"title3":"Novel Wuhan (2019-nCoV) coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus phylogeny: toward consensus"},{"title3":"Diagnosis and treatment of new coronavirus pneumonia (trial version 7) [J / OL]. Tianjin J Tradit Chin Med. 2020;1-5. http://kns.cnki.net/kcms/detail/12.1349.R.20200304.1638.006.html. Accessed 3 June 2020."},{"title3":"Clinical outcome of standardized oxygen therapy nursing strategy in COVID-19"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus"},{"title3":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV"},{"title3":"Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients"},{"title3":"Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study"},{"title3":"C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early"},{"title3":"Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Human ipsc-derived cardiomyocytes are susceptible to Sars-Cov-2 infection"},{"title3":"Cardiovascular complications in COVID-19"},{"title3":"COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"}]},{"title2":"Return of the Coronavirus: 2019-nCoV","References":[{"title3":"Wuhan Municipal Health and Health Commission's Briefing on the Current Pneumonia Epidemic Situation in Our City"},{"title3":"New Virus Discovered by Chinese Scientists Investigating Pneumonia Outbreak"},{"title3":"WHO Statement Regarding Cluster of Pneumonia Cases in Wuhan, China"},{"title3":"Novel 2019 Coronavirus Genome"},{"title3":"2020 Coronavirus"},{"title3":"Novel Coronavirus:Japan (ex-China)"},{"title3":"Laboratory Testing for 2019 Novel Coronavirus (2019-nCoV) in Suspected Human Cases"},{"title3":"Estimating the Potential Total Number of Novel Coronavirus (2019-nCoV) Cases in Wuhan City, China"},{"title3":"Wuhan Municipal Commission of Health and Health on Pneumonia of New Coronavirus Infection"},{"title3":"Super-spreaders in infectious diseases"},{"title3":"Wuhan Virus: China Locks down Huanggang, Shuts Down Railway Station in Ezhou after Wuhan Lockdown"},{"title3":"Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross-species transmission from snake to human"},{"title3":"nCoV's Relationship to Bat Coronaviruses and Recombination Signals No Snakes"},{"title3":"Molecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus-like virus in palm civets at an animal market and on farms"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence"},{"title3":"SARS-like WIV1-CoV poised for human emergence"},{"title3":"Serological Evidence of Bat SARS-Related Coronavirus Infection in Humans, China"},{"title3":"Further Evidence for Bats as the Evolutionary Source of Middle East Respiratory Syndrome Coronavirus"},{"title3":"Identification of a severe acute respiratory syndrome coronavirus-like virus in a leaf-nosed bat in Nigeria"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Middle East Respiratory Syndrome: Emergence of a Pathogenic Human Coronavirus"},{"title3":"Viral Loads in Clinical Specimens and SARS Manifestations"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: A descriptive study"},{"title3":"Risk Factors for Fatal Middle East Respiratory Syndrome Coronavirus Infections in Saudi Arabia: Analysis of the WHO Line List, 2013-2018"},{"title3":"SARS Severe Acute Respiratory Syndrome"},{"title3":"MERS-CoV"},{"title3":"Preliminary Phylogenetic Analysis of 11 nCoV2019 Genomes, 2020-01-19"},{"title3":"Genomic Epidemiology of Novel Coronavirus (nCoV) Using Data Generated by Fudan University, China CDC, Chinese Academy of Medical Sciences, Chinese Academy of Sciences and the Thai National Institute of Health Shared via GISAID"},{"title3":"Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin"},{"title3":"Jumping species-a mechanism for coronavirus persistence and survival"},{"title3":"Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice"},{"title3":"The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2"},{"title3":"Bat Severe Acute Respiratory Syndrome-Like Coronavirus WIV1 Encodes an Extra Accessory Protein, ORFX, Involved in Modulation of the Host Immune Response"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Functional assessment of cell entry and receptor usage for lineage B beta-coronaviruses, including 2019-nCoV"},{"title3":"Viruses and Koch's Postulates"},{"title3":"A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice"},{"title3":"Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys"},{"title3":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome"},{"title3":"Host species restriction of Middle East respiratory syndrome coronavirus through its receptor, dipeptidyl peptidase 4"},{"title3":"Mouse dipeptidyl peptidase 4 is not a functional receptor for Middle East respiratory syndrome coronavirus infection"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques"},{"title3":"15 Medical Staff in Wuhan Confirmed New Coronavirus Pneumonia, and Another Suspected"},{"title3":"Asymptomatic Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: Extent and implications for infection control: A systematic review"},{"title3":"MERS, SARS, and Ebola: The Role of Super-Spreaders in Infectious Disease"},{"title3":"Analysis of intrapatient heterogeneity uncovers the microevolution of Middle East respiratory syndrome coronavirus"}]},{"title2":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","References":[{"title3":"The 2019-nCoV Outbreak Joint Field Epidemiology Investigation Team, Li Q. Notes from the field: an outbreak of NCIP (2019-nCoV) infection in China : Wuhan, Hubei Province, 2019-2020."},{"title3":"A novel coronavirus genome identified in a cluster of pneumonia cases : Wuhan, China 2019-2020."},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Use of national pneumonia surveillance to describe influenza A(H7N9) virus epidemiology, China, 2004-2013."},{"title3":"A novel coronavirus emerging in China : key questions for impact assessment."},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus."},{"title3":"Transmission dynamics and control of severe acute respiratory syndrome."},{"title3":"Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future."},{"title3":"Coronavirus infections : more than just the common cold."},{"title3":"Another decade, another coronavirus."},{"title3":"SARS and MERS: recent insights into emerging coronaviruses."},{"title3":"MERS, SARS, and Ebola: the role of super-spreaders in infectious disease."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at January 2020."},{"title3":"How to maintain surveillance for novel influenza A H1N1 when there are too many cases to count."}]},{"title2":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","References":[{"title3":"CHP closely monitors cluster of pneumonia cases on Mainland"},{"title3":"CHP provides further information on cluster of pneumonia cases in Wuhan"},{"title3":"Wuhan wet market closes amid pneumonia outbreak"},{"title3":"Viral load in patients infected with pandemic H1N1 2009 influenza A virus"},{"title3":"Saliva as a diagnostic specimen for testing respiratory virus by a point-of-care molecular assay: a diagnostic validity study"},{"title3":"Evaluation of NxTAG Respiratory pathogen panel and comparison with xTAG respiratory viral panel fast v2 and film array respiratory panel for detecting respiratory pathogens in nasopharyngeal aspirates and swine/avian-origin influenza A subtypes in culture isolates"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Zika virus infection in dexamethasone-immunosuppressed mice demonstrating disseminated infection with multi-organ involvement including orchitis effectively treated by recombinant type I interferons"},{"title3":"High prevalence of four novel astrovirus genotype species identified from rodents in China"},{"title3":"Metagenomic analysis of viromes of dromedary camel fecal samples reveals large number and high diversity of circoviruses and picobirnaviruses"},{"title3":"Identification of a novel bat papillomavirus by metagenomics"},{"title3":"Metagenomic nanopore sequencing of influenza virus direct from clinical respiratory samples"},{"title3":"Severe acute respiratory syndrome (SARS) coronavirus ORF8 protein is acquired from SARS-related coronavirus from greater horseshoe bats through recombination"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection"},{"title3":"A patient with asymptomatic severe acute respiratory syndrome (SARS) and antigenemia from the 2003-2004 community outbreak of SARS in Guangzhou, China"},{"title3":"Viral replication in the nasopharynx is associated with diarrhea in patients with severe acute respiratory syndrome"},{"title3":"Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease"},{"title3":"Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus"},{"title3":"Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"Viral loads in clinical specimens and SARS manifestations"},{"title3":"Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome"},{"title3":"Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia"},{"title3":"Discovery of seven novel mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus"},{"title3":"Discovery of a novel coronavirus, China Rattus coronavirus HKU24, from Norway rats supports the murine origin of Betacoronavirus 1 and has implications for the ancestor of Betacoronavirus lineage A"},{"title3":"Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Antigenic cross-reactivity between severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43"}]},{"title2":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"New coronavirus pneumonia prevention and control program (6th ed) (in Chinese). 2020. http://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2/files/b218cfeb1bc54639af227f922bf6b817.pdf.","References":[]},{"title2":"World Health Organization. Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance. 2020. https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected.","References":[]},{"title2":"KDIGO clinical practice guidelines for acute kidney injury","References":[]},{"title2":"NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study","References":[]},{"title2":"Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention","References":[]},{"title2":"World Health Organization. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. 2003. https://www.who.int/csr/sars/country/table2004_04_21/en/.","References":[]},{"title2":"World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV). 2019. https://www.who.int/emergencies/mers-cov/en/.","References":[]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"[The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]","References":[{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"}]},{"title2":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series [correction in: BMJ 2020;368:m792]","References":[]},{"title2":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","References":[{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China"},{"title3":"Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014"}]},{"title2":"Can we contain the COVID-19 outbreak with the same measures as for SARS?","References":[{"title3":"Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan"},{"title3":"ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Transmission dynamics and control of severe acute respiratory syndrome"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia"},{"title3":"Isolation, quarantine, social distancing and community containment: pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak"},{"title3":"Battling 21st-century scourges with a 14th-century toolbox"},{"title3":"Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome"},{"title3":"Predicting super spreading events during the 2003 severe acute respiratory syndrome epidemics in Hong Kong and Singapore"},{"title3":"Modelling strategies for controlling SARS outbreaks"},{"title3":"Household transmission of SARS, 2003"},{"title3":"Epidemiology and control of SARS in Singapore"},{"title3":"Hospitalized patients with bacterial infections: a potential focus of SARS transmission during an outbreak"},{"title3":"Public health and ethical considerations in planning for quarantine"},{"title3":"Public health measures to control the spread of the severe acute respiratory syndrome during the outbreak in Toronto"},{"title3":"SARS: public health measures in Hong Kong"},{"title3":"Controlling SARS: a review on China's response compared with other SARS-affected countries"},{"title3":"The impact of public health control measures during the SARS epidemic in mainland China"},{"title3":"A tale of two cities: community psychobehavioral surveillance and related impact on outbreak control in Hong Kong and Singapore during the severe acute respiratory syndrome epidemic"},{"title3":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients"},{"title3":"SARS in healthcare facilities, Toronto and Taiwan"},{"title3":"SARS in Singapore:key lessons from an epidemic"},{"title3":"Experience of severe acute respiratory syndrome in Singapore: importation of cases, and defense strategies at the airport"},{"title3":"The severe acute respiratory syndrome: impact on travel and tourism"},{"title3":"SARS to novel coronavirus:old lessons and new lessons"},{"title3":"A novel coronavirus outbreak of global health concern"},{"title3":"China's response to a novel coronavirus stands in stark contrast to the 2002 SARS outbreak response"},{"title3":"Travelers give wings to novel coronavirus (2019-nCoV)"},{"title3":"Potential for global spread of a novel coronavirus from China"},{"title3":"Pneumonia of unknown etiology in Wuhan, China: potential for international spread via commercial air travel"},{"title3":"Asymptomatic SARS coronavirus infection among healthcare workers, Singapore"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"Effectiveness of airport screening at detecting travellers infected with novel coronavirus (2019-nCoV)"},{"title3":"The reproductive number of COVID-19 is higher compared to SARS coronavirus"},{"title3":"COVID-19 outbreak on the Diamond Princess cruise ship: estimating the epidemic potential and effectiveness of public health countermeasures"},{"title3":"The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19):China, 2020. China CDC Weekly 2020"}]},{"title2":"Clinical and laboratory features of severe acute respiratory syndrome vis-a-vis onset of fever","References":[{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"SARS coronavirus sequencing"},{"title3":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong"},{"title3":"Case definitions for surveillance of severe acute respiratory syndrome (SARS): revised 1 May 2003"},{"title3":"Pneumonia due to viral and atypical organisms and their sequelae"},{"title3":"Pneumonia: high-resolution CT findings in 114 patients"},{"title3":"Imaging of pneumonia: trends and algorithms"},{"title3":"Aetiology of community-acquired pneumonia: a prospective study among adults requiring admission to hospital"},{"title3":"Differentiation of bacterial and viral pneumonia in children"},{"title3":"Hospital infection control guidance for severe acute respiratory syndrome (SARS): revised 24 April 2003"},{"title3":"Personal view of SARS: confusing definition, confusing diagnoses"},{"title3":"The immediate psychological and occupational impact of the 2003 SARS outbreak in teaching hospital"},{"title3":"Development of a standard treatment protocol for severe acute respiratory syndrome"},{"title3":"Severe acute respiratory syndrome: radiographic appearances and pattern of progression in 138 patients"},{"title3":"Cluster of severe acute respiratory syndrome cases among protected health-care workers: Toronto, Canada, April 2003"},{"title3":"Interim domestic guidance for management of exposures to severe acute respiratory syndrome (SARS) for health-care settings"},{"title3":"Clinical course and management of SARS in health care workers in Toronto: a case series"},{"title3":"Identification and containment of an outbreak of SARS in a community hospital"},{"title3":"Investigation of a nosocomial outbreak of severe acute respiratory syndrome (SARS) in Toronto, Canada"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Clinical presentations and outcome of severe acute respiratory syndrome in children"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"An outbreak of coronavirus OC43 respiratory infection in Normandy, France"},{"title3":"Severe acute respiratory syndrome: clinical outcome and prognostic correlates"}]}]}]}